Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036432	ex-tbvi	— (—)	1979	7792	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

678

1132

5.28

315.64

4.4

3.6

—

ILD, hospital admission 2, with pulmonary infections

236

114

21.79

315.33

4.3

3.1

—

Chronic lower respiratory diseases

929

747

6.61

307.65

4.6

3.0

—

COPD

527

522

8.36

307.65

4.0

2.9

—

Asthma, hospital admission 2, infections

587

941

6.16

307.65

4.8

3.6

—

Influenza and pneumonia

791

814

6.05

307.65

4.5

3.4

—

Abnormal findings on diagnostic imaging of lung

610

937

6.29

307.65

4.5

3.6

—

Asthma (only as main-diagnosis)

612

145

23.88

307.65

4.5

2.8

—

Asthma, excluding more controls

560

121

24.01

307.65

4.5

2.9

—

Other chronic obstructive pulmonary disease

507

506

8.36

307.65

4.0

2.9

—

Bronchiectasis

293

101

31.72

307.65

7.2

2.6

—

Early onset COPD, excluding more controls

239

33.00

307.65

4.4

2.7

—

Pneumonia, organism unspecified

810

804

6.99

307.65

4.4

3.4

—

Asthma, unspecified (mode), excluding more controls

471

119

28.70

307.65

4.4

2.9

—

Asthma/COPD (KELA code 203)

728

746

6.58

307.65

4.7

2.9

—

Asthma (only as main-diagnosis), excluding more controls

579

121

26.77

307.65

4.5

2.9

—

Asthma

589

145

21.17

307.65

4.5

2.8

—

COPD (mode)

373

100

29.72

307.65

4.0

2.6

—

Asthma-related infections

587

941

6.16

307.65

4.8

3.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

737

569

7.65

307.65

4.7

3.1

—

Pneumonias (Asthma/COPD co-morbidities)

820

819

6.60

307.65

4.8

3.1

—

Oral corticosteroids

869

894

5.75

307.65

4.3

3.4

—

All pneumoniae

806

833

6.35

307.65

4.4

3.5

—

737

569

7.65

307.65

4.7

3.1

—

Asthma, unspecified (mode)

490

143

25.06

307.65

4.3

2.8

—

Asthma (mode)

517

147

18.65

307.65

4.3

2.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

805

853

6.35

307.65

4.4

3.6

—

Asthma (diagnoses ohter than nonallergic)

730

1213

4.91

305.39

4.5

3.5

—

Asthma-related pneumonia

460

663

7.05

300.63

5.1

3.6

—

Asthma, hospital admissions 3, pneumonia

460

664

7.04

300.19

5.1

3.6

—

Asthma-related pneumonia or sepsis

460

664

7.04

300.19

5.1

3.6

—

ILD, hospital admissions 3, with pneumonia sepsis

217

104

22.07

291.09

4.4

3.2

—

Inflammatory bowel disease treatment related agents

798

898

4.97

289.19

4.3

3.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

764

833

5.14

286.86

4.2

3.6

—

Later onset COPD, excluding more controls

242

26.20

286.25

3.7

2.6

—

Haemorrhage from respiratory passages

395

451

7.89

270.72

4.5

3.2

—

Asthma and opportunity respiratory infection

183

28.53

267.86

7.5

3.5

—

Undetermined asthma, excluding more controls

155

43.99

260.73

4.8

2.5

—

Other pulmonary diagnosis

385

147

13.21

259.78

4.2

2.8

—

Asthma, hospital admissions , main diagnosis only

647

1235

4.60

257.71

4.5

3.6

—

412

618

6.70

257.44

5.1

3.6

—

Other chronic obstructive pulmonary disease, including avohilmo

576

931

5.16

255.48

4.2

3.7

—

Other diseases of pleura

532

864

5.45

255.25

3.8

4.0

—

ILD medications

738

836

4.79

254.32

4.1

3.6

—

Respiratory insufficiency

146

50.36

252.24

3.8

2.5

—

Excluding asthma or asthma-COPD overlap

375

147

12.86

250.09

4.2

2.8

—

Undetermined asthma

155

36.83

249.27

4.8

2.5

—

COPD differential diagnosis

374

147

12.83

249.15

4.2

2.8

—

Non-allergic asthma (mode), excluding more controls

170

27.60

249.06

5.2

2.5

—

ILD differential diagnosis

373

147

12.79

248.17

4.2

2.8

—

Non-allergic asthma (mode)

170

25.54

242.35

5.2

2.6

—

Cough

364

476

7.23

237.77

4.1

3.4

—

COPD, hospital admissions

516

853

5.19

232.09

4.0

3.8

—

First line medication for Crohn's disease

690

802

4.66

230.71

4.2

3.6

—

COPD, early/later onset

515

852

5.16

230.17

4.0

3.8

—

Other interstitial pulmonary diseases

291

344

8.79

227.69

4.1

3.8

—

ILD, hospital admissions

288

337

8.88

227.21

4.1

3.8

—

Interstitial lung disease endpoints

291

347

8.71

226.11

4.1

3.8

—

Interstitial lung disease

291

347

8.71

226.11

4.1

3.8

—

Other respiratory diseases principally affecting the interstitium

309

410

7.79

219.31

4.0

3.8

—

COPD, hospital admission 2, with asthma infections

418

619

5.94

218.12

4.2

3.8

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

380

533

6.25

208.03

4.3

3.7

—

Asthma, including avohilmo

777

1126

3.83

207.65

4.3

3.6

—

Abnormalities of breathing

548

619

5.10

207.31

4.3

3.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

222

16.30

206.49

4.2

3.3

—

COPD/asthma related infections

570

569

5.05

200.40

4.5

3.1

—

COPD/asthma/ILD related infections

570

569

5.05

200.40

4.5

3.1

—

Lung cancer and mesothelioma

168

20.11

195.92

2.9

2.6

—

Dyspnoea

650

1250

3.78

189.18

4.0

3.9

—

COPD related to multimorbidity

438

761

4.95

187.33

4.0

3.9

—

ILD, hospital admissions 1, main diag only

249

313

8.26

185.33

4.0

3.7

—

COPD, hospital admissions 1, only main diagnosis

405

703

5.04

177.94

4.2

3.7

—

Obesity related asthma

309

526

5.96

172.49

4.6

3.8

—

Diseases of the respiratory system

280

142

9.94

164.29

4.5

3.0

—

Other acute lower respiratory infections

446

1018

4.21

164.02

4.7

3.6

—

Infection due to other mycobacteria

53.70

152.39

14.4

2.8

—

ILD medications: immunosuppressive drugs

366

718

4.65

150.36

4.2

3.7

—

Acute bronchitis

369

814

4.50

148.82

4.8

3.6

—

Infection due to other mycobacteria, including avohilmo

43.79

145.48

14.4

2.9

—

Atypical mycobacterium lung infection

82.89

141.94

15.9

5.5

—

646

979

3.36

140.41

4.8

3.3

—

Other diseases of the respiratory system

263

480

5.60

136.80

4.2

3.9

—

Other respiratory disorders and diseases

263

480

5.60

136.80

4.2

3.9

—

Early onset COPD

239

402

6.06

135.39

4.4

3.8

—

Fever of other and unknown origin

393

857

4.00

131.47

4.3

3.9

—

Bacterial pneumoniae

275

490

4.97

120.91

4.6

3.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

581

1301

3.03

118.45

4.1

3.8

—

Emphysema

119

104

11.83

115.84

4.3

3.1

—

Symptoms and signs involving the circulatory and respiratory systems

459

619

3.73

114.87

4.3

3.5

—

Persons encountering health services in other circumstances

280

623

4.49

113.30

3.4

4.0

—

Bronchitis

620

1291

2.89

113.06

4.8

3.5

—

Persons encountering health services in other circumstances, wide

622

1087

2.96

111.49

4.0

3.9

—

21.17

110.70

7.7

3.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

590

1075

2.93

105.51

4.1

3.9

—

Simple and mucopurulent chronic bronchitis

17.31

103.45

5.5

2.7

—

Chronic sinusitis

287

728

3.97

99.21

5.3

3.7

—

Bleeding

511

1257

2.87

96.14

4.3

3.8

—

Pleural effusion

176

312

5.76

94.58

3.7

3.9

—

Later onset COPD

282

564

4.08

93.92

3.7

—

Heart failure, not strict

454

1011

3.04

93.17

3.6

4.2

—

All influenza

167

289

5.83

91.73

5.3

3.1

—

Bacterial pneumonia (organism specified)

319

826

3.53

90.39

4.6

3.4

—

Asthma mixed form (mode), excluding more controls

52.03

88.61

4.3

2.6

—

Other bacterial diseases

518

1263

2.73

87.79

5.2

3.4

—

Unspecified chronic bronchitis

17.09

86.09

4.7

2.7

—

Viral pneumonia

113

139

8.26

85.38

4.7

3.1

—

Asthma mixed form (mode)

43.36

85.17

4.3

2.8

—

Heart failure,strict

370

806

3.23

84.82

3.5

4.1

—

COPD-related respiratory insufficiency

145

239

6.21

84.12

3.7

3.9

—

Presence of other functional implants

408

929

3.03

83.82

4.3

3.7

—

Implicit Sepsis

450

1188

2.81

82.70

3.9

4.0

—

Bacterial pneumonia, not elsewhere classified

226

470

4.25

82.56

4.9

3.2

—

Morphin

18.45

78.87

4.1

3.4

—

Other bacterial diseases, including avohilmo

507

1223

2.60

77.05

5.0

3.4

—

Other medical care

341

933

3.09

76.83

3.7

4.1

—

All-cause Heart Failure

401

985

2.85

74.68

3.5

4.0

—

Heart failure, strict

404

999

2.83

74.22

3.5

4.0

—

Implicit Sepsis, including avohilmo

444

1202

2.65

72.88

3.8

4.0

—

Pain in throat and chest

333

616

3.21

72.08

3.9

3.5

—

Allergic asthma (mode), excluding more controls

11.96

70.58

4.0

3.2

—

Idiopathic pulmonary fibrosis

113

174

6.69

70.26

3.9

3.5

—

Allergic asthma (mode)

10.86

66.31

4.0

3.1

—

Bacterial Sepsis

324

922

2.93

66.29

3.7

3.9

—

Implicit viral Sepsis, including avohilmo

224

650

3.47

63.74

4.3

4.0

—

Implicit viral Sepsis

176

435

4.10

63.53

4.3

4.1

—

Viral Sepsis

176

435

4.10

63.52

4.3

4.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

452

1162

2.47

62.27

4.0

3.8

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

431

1171

2.49

61.83

4.0

3.9

—

Implicit bacterial Sepsis, including avohilmo

310

910

2.85

60.79

3.7

3.8

—

Pleural plaque

115

208

5.66

60.71

3.8

—

Pneumonia due to other infectious organisms, not elsewhere classified

15.40

59.03

4.2

3.7

—

Tramadol

379

869

2.63

58.66

3.6

4.0

—

Diagnoses used for exclusion with ILD

204

596

3.46

57.79

4.4

3.8

—

Persons encountering health services for specific procedures and health care

479

1221

2.32

56.98

3.5

4.1

—

Implicit bacterial Sepsis

285

862

2.86

56.42

3.7

3.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

417

1210

2.40

55.44

3.9

4.0

—

Heart failure and antihypertensive medication

162

248

4.28

53.71

3.4

3.8

—

Suppurative and necrotic conditions of lower respiratory tract

119

7.02

52.71

4.1

3.7

—

Acute sinusitis

248

773

2.93

52.39

5.3

3.7

—

Persons with potential health hazards related to communicable diseases

169

466

3.61

51.36

3.8

4.0

—

General symptoms and signs

438

934

2.36

51.32

3.9

4.0

—

Explicit Sepsis, including avohilmo

276

920

2.74

51.26

3.5

3.9

—

Oxycodone

242

714

2.92

49.88

3.5

4.0

—

Explicit Sepsis

270

908

2.73

49.82

3.5

3.9

—

Infections, IBD-co-morbidities

100

117

6.06

49.58

6.2

3.7

—

Sleep apnoea

454

1297

2.21

49.33

4.3

3.9

—

Vocal cord dysfunction

109

6.68

49.08

5.4

3.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

241

857

2.83

48.81

4.1

—

Septicaemia

262

879

2.74

48.70

3.5

3.4

—

L04AX Other immunosuppressants

282

1089

2.60

48.52

4.3

4.0

—

Asthma and allergy, excluding more controls

17.59

47.40

4.9

2.3

—

Covid-19 confirmed case

243

882

2.77

47.28

4.0

3.9

—

Second line medication for Crohn's disease

284

1116

2.55

47.10

4.3

4.0

—

Heart failure and coronary heart disease

283

747

2.67

47.08

3.4

3.8

—

Contact with and exposure to communicable diseases

129

318

4.06

46.39

4.0

4.1

—

Asthma and allergy

16.82

46.38

4.9

2.3

—

ILD-related respiratory insufficiency

9.13

46.05

4.0

3.8

—

L04AA Selective immunosuppressants

145

394

3.72

45.92

4.1

3.9

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

189

487

3.23

45.62

3.1

4.1

—

Sleep apnoea, including avohilmo

458

1302

2.13

45.06

4.4

3.9

—

Drug-induced adrenocortical insufficiency

18.00

43.93

7.2

4.8

—

Polyarthropathies

330

885

2.40

43.50

3.9

3.8

—

Certain disorders involving the immune mechanism

133

354

3.80

43.45

5.3

3.9

—

Osteoporosis

186

557

3.10

43.28

4.3

3.9

—

Other heart diseases, wide

349

900

2.35

43.26

3.8

4.3

—

FESS (DNB20)

196

4.91

43.25

5.6

4.0

—

ILD medications: azathioprine

132

5.88

42.92

4.8

3.9

—

Other heart diseases

173

330

3.42

42.83

3.8

4.4

—

Percutaneous Coronary Intervention

371

995

2.28

42.70

4.1

4.0

—

Malaise and fatigue

257

776

2.62

42.57

3.7

3.9

—

Heart failure and bmi 25plus

207

462

3.01

42.11

3.4

3.9

—

Adrenocortical insufficiency

9.71

41.70

6.1

3.8

—

Ethmoidectomy

203

4.74

41.48

5.6

4.0

—

Coronary revascularization (ANGIO or CABG)

368

995

2.26

41.46

4.1

4.0

—

Pneumonia due to Streptococcus pneumoniae

10.46

41.43

3.7

3.4

—

Bacterial infection, other or unspecified, including avohilmo

305

1060

2.37

41.30

3.8

3.4

—

Codeine

369

880

2.27

41.01

3.7

4.1

—

Acute upper respiratory infections

467

1376

2.04

40.90

4.7

3.7

—

Other septicaemia, including avohilmo

234

838

2.64

40.90

3.5

3.4

—

Implicit fungal Sepsis, including avohilmo

127

5.86

40.21

5.2

4.2

—

Ischemic heart diseases

375

1014

2.21

40.09

4.0

—

Provisional assignment of new diseases of uncertain etiology

276

1150

2.39

39.74

4.0

3.9

—

Codes for special purposes

276

1150

2.39

39.74

4.0

3.9

—

Aplastic and other anaemias

287

1118

2.36

39.54

3.8

—

Other septicaemia

228

825

2.62

39.46

3.5

—

Azathioprine

143

5.43

39.45

4.8

3.8

—

Certain infectious and parasitic diseases

373

835

2.24

39.40

4.5

3.3

—

Biological medicines for asthma

16.03

39.31

7.2

5.0

—

Pneumocystosis

11.71

39.20

4.2

4.5

—

Pneumocystosis, including avohilmo

11.71

39.20

4.2

4.5

—

Anaemias

5.88

38.98

4.4

4.7

—

Other pleural conditions

190

4.76

38.97

3.5

3.9

—

Reimbursement for rheumatic diseases

275

1158

2.37

38.90

4.1

4.0

—

Major coronary heart disease event

388

1084

2.15

38.84

4.0

3.9

—

Malignant neoplasm of bronchus and lung, including Hilmo

166

445

3.14

38.65

3.0

4.1

—

Atrial fibrillation and flutter

142

252

3.66

38.57

3.8

4.1

—

Other disorders of adrenal gland

8.29

38.55

5.9

3.9

—

Tuberculosis

133

5.61

38.35

6.9

3.4

—

Immunodeficiencies

8.64

38.32

6.0

4.0

—

Atrial fibrillation and flutter with reimbursement

132

217

3.86

38.20

4.1

4.0

—

Acute upper respiratory infections of multiple and unspecified sites

324

1054

2.25

38.08

4.8

3.6

—

Spondylosis

289

966

2.35

38.06

3.8

3.9

—

Any reimbursement code in KELA

151

205

3.70

37.91

4.7

3.6

—

Any gastric operation

275

544

2.54

37.90

4.2

3.7

—

GASTRO-related operations

275

544

2.54

37.90

4.2

3.7

—

Other disorders of fluid, electrolyte and acid-base balance

208

734

2.69

37.79

3.9

—

Opioids

375

888

2.19

37.67

3.6

4.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

294

1304

2.26

37.45

4.1

4.0

—

Osteopathies and chondropathies

285

1132

2.31

37.44

4.1

4.0

—

Bacterial infection, other or unspecified

282

1025

2.33

37.18

3.8

3.4

—

Emergency coronary revascularization (for ACS)

394

1153

2.07

36.02

4.1

3.9

—

Malignant neoplasm of respiratory system and intrathoracic organs

162

444

3.06

35.99

3.1

4.1

—

Renal tubulo-interstitial diseases

386

1387

2.04

35.78

3.8

4.0

—

Hard cardiovascular diseases

358

989

2.15

35.68

4.1

3.9

—

Unspecified acute lower respiratory infection

104

270

3.89

35.28

4.9

3.9

—

Protozoal diseases

8.93

35.07

4.0

3.9

—

Protozoal diseases, including avohilmo

8.92

35.06

4.0

3.9

—

Other anaemias

265

1078

2.31

35.06

3.6

3.8

—

Pleural plaque with presence of asbestos

216

4.32

35.05

3.8

3.5

—

Constipation

414

1418

1.98

34.73

4.0

3.9

—

Non-ischemic cardiomyopathy

191

556

2.74

34.72

3.9

—

Pulmonary heart disease, diseases of pulmonary circulation

198

762

2.62

34.60

3.7

3.8

—

Autoimmune diseases related-to ILD

342

1373

2.09

34.37

4.1

3.9

—

Cardiac arrhythmias

216

528

2.63

34.36

4.0

—

Other and unspecified anaemias

262

1074

2.30

34.32

3.6

3.8

—

Renal failure

285

1096

2.23

33.82

3.6

3.9

—

Lung diseases due to external agents

120

354

3.43

33.76

3.7

3.9

—

Non-small cell lung cancer, including Hilmo

124

347

3.39

33.71

3.1

4.2

—

All chronic kidney diseases

286

1027

2.23

33.63

3.6

3.9

—

Autoimmune diseases excluding thyroid diseases

432

1196

1.96

33.35

4.0

3.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

421

1160

1.98

33.31

4.0

3.8

—

All kidney diseases

399

1354

1.98

33.20

3.9

—

Sulfasalazine

116

339

3.44

33.01

3.7

3.5

—

Sleep disorders (combined)

453

1232

1.93

32.81

3.9

—

Spondylopathies

360

1042

2.05

31.99

3.7

3.9

—

Methotrexate

148

4.84

31.98

4.2

3.5

—

Immunodeficiency with predominantly antibody defects

11.72

31.93

5.5

4.0

—

Pain, not elsewhere classified

135

446

3.04

31.44

3.8

3.9

—

General examination and investigation of persons without complaint and reported diagnosis

296

692

2.23

31.25

3.6

—

Codeine or tramadol medication

458

1328

1.88

31.16

3.8

4.0

—

Abscess of lung

12.50

30.97

4.2

4.6

—

Complications of surgical and medical care, not elsewhere classified

427

1514

1.89

30.92

4.1

3.8

—

Chronic rhinitis, nasopharyngitis and pharyngitis

149

531

2.82

30.28

4.7

3.8

—

Implicit fungal Sepsis

7.04

30.20

5.6

4.2

—

Fungal Sepsis

6.52

29.97

5.8

3.9

—

Other diseases of upper respiratory tract

443

1232

1.88

29.86

4.7

3.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

223

936

2.31

29.62

5.0

3.6

—

Pyothorax

5.83

29.53

4.6

3.9

—

Suggestive for eosinophilic asthma

131

4.95

29.51

4.8

3.9

—

Other diseases of blood and blood-forming organs, wide

136

471

2.91

29.23

3.8

4.2

—

Malignant neoplasm of bronchus and lung

138

394

2.96

29.14

3.0

4.2

—

Benzodiazepine use

420

1532

1.85

29.00

3.9

—

Disorders of other endocrine glands

202

839

2.38

28.96

4.2

3.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

105

4.41

28.64

5.4

2.9

—

Chronic kidney disease

201

819

2.38

28.52

3.5

3.8

—

Venous thromboembolism

279

1302

2.07

28.39

3.5

3.9

—

Systemic connective tissue disorders

185

762

2.44

28.15

4.3

3.8

—

Tuberculosis, wide, including avohilmo

166

4.35

27.89

6.4

3.7

—

DVT of lower extremities and pulmonary embolism

227

1021

2.23

27.86

3.5

3.9

—

Tuberculosis, IBD comorbidity

158

4.44

27.84

6.4

3.7

—

Exclusions for E4_PCOS_BROAD

100

297

3.39

27.82

4.8

4.2

—

Erysipelas, including avohilmo

312

1159

2.00

27.47

3.7

3.4

—

Respiratory tuberculosis, confirmed and not-confirmed

109

5.24

27.43

7.4

3.5

—

Respiratory tuberculosis

109

5.24

27.43

7.4

3.5

—

Respiratory tuberculosis, confirmed, including avohilmo

10.73

27.27

8.7

4.3

—

Dysphagia

144

534

2.72

27.23

3.6

3.9

—

Tuberculosis, wide

165

4.31

27.22

6.4

3.7

—

Liquid cancers

168

633

2.53

27.19

3.4

4.1

—

Bronchitis, not specified as acute or chronic

5.82

27.08

4.9

3.1

—

Certain infectious and parasitic diseases, including avohilmo

273

631

2.17

27.01

4.5

3.3

—

Parasetamol

238

524

2.30

26.95

3.9

4.1

—

Iron deficiency anaemia

225

1006

2.20

26.94

4.1

3.7

—

Pulmonary embolism

172

703

2.46

26.65

3.6

3.8

—

Enlarged lymph nodes

262

3.50

26.62

3.9

4.2

—

Respiratory tuberculosis, confirmed

10.73

26.37

8.9

4.4

—

Headache

231

813

2.20

26.35

3.9

4.0

—

Liquid cancers, including Hilmo

190

712

2.37

26.29

3.4

4.2

—

Pulmonary heart disease

172

710

2.44

26.09

3.6

3.9

—

Hypo-osmolality and hyponatraemia

121

416

2.91

26.00

3.8

4.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

103

211

3.38

25.80

3.8

3.9

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

9.71

25.44

8.7

4.2

—

Viral pneumonia (known virus, not influenza)

8.47

25.34

4.5

3.8

—

Pain in limb

335

1114

1.92

25.27

3.6

3.9

—

Other systemic involvement of connective tissue (FG)

136

500

2.69

25.15

4.2

4.0

—

Vasomotor and allergic rhinitis

138

509

2.66

25.07

4.5

3.7

—

Mycoses

152

605

2.53

24.96

4.8

3.9

—

Concussion

202

691

2.27

24.94

4.0

—

Abnormalities of heart beat

124

433

2.79

24.63

3.5

—

Rheumatoid arthritis

164

597

2.44

24.49

4.4

4.0

—

Disorders of lens

288

907

1.98

23.63

4.1

3.9

—

Nutritional anaemias

251

1195

2.01

23.59

4.2

3.8

—

Pneumothorax

117

4.68

23.36

4.5

3.6

—

Other soft tissue disorders, not elsewhere classified

363

1132

1.83

23.20

3.5

3.9

—

Finngen Rheumatological endpoints

351

1081

1.85

23.16

3.8

4.0

—

Viral pneumonia (unknown virus, not influenza)

5.23

23.15

3.7

4.4

—

Paroxysmal tachycardia

219

3.35

23.06

4.2

4.4

—

Other symptoms and signs involving the circulatory and respiratory systems

5.65

23.03

5.6

3.6

—

Diseases of oesophagus, stomach and duodenum

411

1390

1.75

22.92

4.0

3.8

—

L04AD Calcineurin inhibitors

162

3.99

22.64

4.3

—

Valvular heart disease excluding rheumatic fever

199

645

2.21

22.62

3.4

4.3

—

Other antidepressants

407

1185

1.76

22.28

4.0

—

Other disorders of white blood cells

5.03

22.10

4.4

3.7

—

Syncope and collapse

191

729

2.19

22.09

3.6

3.8

—

Low back pain

297

1063

1.89

21.93

4.4

4.0

—

Ischaemic heart disease, wide definition

330

1108

1.84

21.89

3.7

4.0

—

Non-rheumatic valve diseases

197

645

2.19

21.84

3.4

4.3

—

Seropositive rheumatoid arthritis

129

506

2.55

21.64

4.5

4.0

—

Invasive ventilation

133

4.27

21.62

2.9

4.0

—

Acute renal failure

136

551

2.49

21.61

3.9

3.8

—

Intracranial trauma

216

694

2.11

21.59

4.0

—

Other cataract

207

727

2.12

21.54

4.3

3.9

—

Cardiovascular diseases (excluding rheumatic etc)

156

364

2.46

21.22

3.9

4.3

—

Transplanted organ and tissue status

140

4.11

21.02

4.3

3.9

—

Gastro-oesophageal reflux disease

287

1308

1.86

20.94

4.1

3.9

—

Oedema, not elsewhere classified

147

610

2.36

20.91

3.8

—

Hypertensive diseases (excluding secondary)

143

330

2.53

20.71

4.7

4.4

—

Hypertension, essential

270

794

1.93

20.29

4.2

4.0

—

Episodal and paroxysmal disorders

391

1150

1.73

20.26

3.8

3.9

—

Other systemic involvement of connective tissue

137

575

2.40

20.17

4.2

3.8

—

Other arrhythmias

222

825

2.01

20.16

4.0

4.2

—

Other and unspecified dermatitis

225

1148

1.97

20.16

3.9

—

Senile cataract

266

846

1.92

20.06

4.0

3.9

—

Problems related to lifestyle

116

4.34

19.87

3.1

4.0

—

Dermatitis

266

1410

1.85

19.76

3.9

3.8

—

Erysipelas

240

1079

1.92

19.65

3.8

3.4

—

Coronary atherosclerosis

271

909

1.89

19.63

3.6

3.9

—

Other and unspecified iron deficiency

166

766

2.17

19.44

4.3

3.7

—

Non-invasive ventilation

265

2.94

19.31

3.7

4.0

—

Acute tubulo-interstitial nephritis

263

1202

1.85

19.12

3.8

4.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

275

1352

1.82

19.12

3.8

4.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

139

603

2.32

19.04

3.5

3.9

—

Symptoms and signs involving the digestive system and abdomen

363

1053

1.73

18.91

3.7

4.0

—

Rheumatoid arthritis, including avohilmo

177

849

2.09

18.88

4.3

3.8

—

Non-small cell lung cancer

256

3.08

18.85

3.1

4.4

—

Diseases of arteries, arterioles and capillaries

308

1281

1.77

18.77

3.6

3.9

—

Gout

157

612

2.21

18.70

3.3

3.6

—

Autoimmune diseases

397

1201

1.68

18.69

3.8

—

Disorders of gallbladder, biliary tract and pancreas

391

1463

1.67

18.66

4.1

3.9

—

Special screening examination for other diseases and disorders

220

3.25

18.61

4.6

3.9

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

6.73

18.36

3.3

4.3

—

Chronic lymphocytic leukaemia, helper endpoint

6.73

18.36

3.3

4.3

—

Chronic lymphocytic leukaemia

6.73

18.36

3.3

4.3

—

Other arthritis (FG)

135

588

2.31

18.31

4.3

4.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

129

552

2.35

18.25

4.5

3.7

—

Used for control exclusion in common control thyroid runs

374

1117

1.69

18.02

3.8

—

Biological medication for rheuma

240

3.10

18.02

3.6

4.5

—

Intestinal infectious diseases

359

1600

1.67

17.97

4.1

3.9

—

Abdominal and pelvic pain

358

1053

1.71

17.94

3.7

4.0

—

Diseases of the skin and subcutaneous tissue

358

1053

1.71

17.89

4.1

3.7

—

Other diseases of intestines

371

1232

1.68

17.88

3.8

4.1

—

Use of hypnotics and sedatives

400

1393

1.64

17.84

4.0

—

Metabolic disorders

355

1261

1.69

17.83

4.2

3.9

—

Substance use, excluding alcohol

300

2.85

17.83

3.9

4.3

—

Hernia of abdominal wall, postoperative

283

2.89

17.65

3.3

3.7

—

Nausea and vomiting

123

509

2.37

17.63

3.6

4.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

174

3.49

17.56

4.5

3.8

—

Any death

277

1084

1.79

17.55

3.4

4.1

—

Dorsalgia

348

1083

1.71

17.51

4.0

—

Cardiodefibrillation

189

953

1.99

17.49

4.0

3.9

—

Candidiasis, including avohilmo

131

575

2.29

17.48

5.3

3.9

—

Other/unspecified seropositive rheumatoid arthritis

129

569

2.28

17.04

4.5

3.7

—

Carrier of infectious disease

7.66

17.02

3.8

5.0

—

Presbycusis

377

2.59

16.99

4.7

3.6

—

Complications of procedures, not elsewhere classified

312

1482

1.70

16.90

4.0

3.9

—

Aspergillosis

19.21

16.74

6.7

5.5

—

Aspergillosis, including avohilmo

19.16

16.73

6.7

5.5

—

Care involving use of rehabilitation procedures

234

1151

1.83

16.73

3.5

4.1

—

Fitting and adjustment of other devices

176

771

2.02

16.69

3.2

4.0

—

Osteoporosis with pathological fracture (FG)

124

3.92

16.62

3.4

4.5

—

Factors influencing health status and contact with health services

103

190

2.73

16.56

4.9

3.6

—

Sarcoidosis

259

2.92

16.43

5.7

4.1

—

Other specified/unspecified arthritis

120

522

2.31

16.39

4.5

4.1

—

Other symptoms and signs involving the urinary system

244

2.98

16.33

3.5

4.1

—

Seropositive rheumatoid arthritis, wide

129

580

2.24

16.31

4.5

3.7

—

Conduction disorders

132

472

2.25

16.22

3.3

4.4

—

All influenza (not pneumonia)

145

3.60

16.11

5.2

3.1

—

Cardiovascular diseases

132

299

2.35

16.10

4.1

4.5

—

Symptoms and signs concerning food and fluid intake

185

3.26

15.89

4.1

4.4

—

Other general symptoms and signs

5.25

15.86

4.2

4.0

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.25

15.79

4.1

4.6

—

Childhood asthma (age<16)

16.97

15.75

4.9

2.3

—

Childhood asthma (age<16), excluding more controls

16.97

15.75

4.9

2.3

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

332

1578

1.64

15.69

4.5

3.9

—

Other functional intestinal disorders

197

949

1.89

15.62

3.6

4.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

40.18

15.55

6.3

6.4

—

ILD medications: nintedanib

31.60

15.53

4.0

3.3

—

Viral infections characterized by skin and mucous membrane lesions

171

871

1.97

15.51

4.6

3.8

—

Myocardial infarction

210

787

1.87

15.32

3.5

3.8

—

Injuries to the thorax

206

1123

1.84

15.21

4.0

3.9

—

Pneumonia due to Haemophilus influenzae

35.79

15.20

6.8

6.7

—

Symptoms and signs involving the urinary system

306

1391

1.66

15.16

3.8

3.9

—

Non-Hodgkin lymphoma, all, including Hilmo

277

2.77

15.11

3.3

4.4

—

Other disorders of ear

343

1368

1.62

15.04

4.6

3.9

—

Other disorders of urethra and urinary system

278

1135

1.71

15.00

3.8

3.9

—

Extreme obesity with alveolar hypoventilation

4.86

14.99

3.7

4.0

—

Explicit bacterial Sepsis

208

3.05

14.97

3.8

—

Conductive and sensorineural hearing loss

319

1287

1.65

14.96

4.3

3.9

—

Other reaction to severe stress, and adjustment disorders

117

524

2.24

14.91

3.9

4.1

—

Streptococcal septicaemia

168

3.30

14.88

3.5

3.4

—

Chronic laryngitis and laryngotracheitis

263

2.80

14.83

4.2

3.8

—

Exposure to unspecified factor

369

1586

1.58

14.83

3.9

4.0

—

Non-small cell lung cancer, squamous

103

4.04

14.79

3.3

3.7

—

Seropositive rheumatoid arthritis, strict definition

286

2.71

14.77

4.8

3.8

—

Gout, FINNGEN

157

786

1.99

14.76

3.3

3.8

—

Explicit bacterial Sepsis, including avohilmo

211

3.01

14.61

3.8

—

Major coronary heart disease event excluding revascularizations

247

930

1.76

14.58

3.7

3.8

—

Chronic apical periodontitis

396

1421

1.56

14.52

4.2

3.9

—

Rheumatism, unspecified

212

2.99

14.49

3.6

4.3

—

Hypertensive diseases

250

802

1.76

14.40

4.0

4.1

—

Unknown and unspecified causes of morbidity

105

3.94

14.39

3.8

3.9

—

Hypertension

250

802

1.76

14.39

4.0

4.1

—

Other CVD (FINNGEN)

125

3.38

14.36

4.8

3.9

—

Injuries to the head

399

1529

1.55

14.23

3.8

4.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

114

312

2.31

14.13

4.5

4.2

—

Lower back pain or/and sciatica

390

1564

1.55

14.11

4.3

3.9

—

Streptococcal septicaemia, including avohilmo

174

3.19

14.08

3.5

3.4

—

Non-selective monoamine reuptake inhibitors

151

731

1.99

14.06

3.8

4.1

—

Unspecified haematuria

204

917

1.82

14.05

3.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

242

693

1.77

13.89

4.3

3.6

—

Other/unspecified rheumatoid arthritis

262

2.73

13.83

5.2

3.9

—

Lung transplant status

19.45

13.58

6.8

5.9

—

Lung transplantation

19.44

13.58

6.8

5.9

—

Other specified/unspecified systemic involvement of connective tissue

4.45

13.55

4.3

4.4

—

Abnormal results of function studies

110

3.76

13.50

3.5

3.9

—

Sensorineural hearing loss

305

1258

1.62

13.41

4.2

3.9

—

Budesonide

144

3.35

13.37

4.1

3.5

—

Substance abuse, excluding more controls

216

1031

1.75

13.34

3.5

3.9

—

Pneumonia derived septicemia

5.39

13.27

4.3

3.5

—

5-aminosalicylic acid

208

2.89

13.11

4.7

3.6

—

Personality disorders, excluding more controls

315

2.51

13.09

3.7

4.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

411

1516

1.51

12.97

4.1

3.9

—

Cerebrovascular diseases (FINNGEN)

264

2.42

12.93

3.5

4.2

—

Pacemaker

188

975

1.80

12.85

3.4

3.9

—

Weight loss

212

2.85

12.72

4.1

4.2

—

Cholelithiasis, broad definition with cholecystitis

331

1409

1.57

12.69

3.8

3.9

—

Malignant neoplasm, including Hilmo

287

1027

1.63

12.65

3.6

4.1

—

Gout, idiopatic and unspecified

138

704

1.97

12.64

3.4

4.0

—

Endocarditis

4.82

12.62

3.0

3.6

—

Complications of medical and surgical care

281

1575

1.61

12.61

4.4

3.9

—

Spinal stenosis

216

919

1.74

12.61

3.8

3.9

—

Sequelae of external causes of morbidity and mortality

122

596

2.06

12.60

3.9

3.8

—

Gout, unspecified

116

557

2.10

12.56

3.3

3.9

—

AV-block

313

2.39

12.51

2.9

4.3

—

Depression or dysthymia

245

788

1.70

12.50

4.1

3.8

—

Drug-induced osteoporosis with pathological fracture

11.96

12.40

3.7

6.1

—

Abnormal findings on examination of blood, without diagnosis

214

1133

1.71

12.36

4.7

3.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

363

2.36

12.26

3.5

3.7

—

Pleural plaque without asbestos

104

3.73

12.26

4.3

3.5

—

Malignant neoplasm, wide definition

286

1031

1.62

12.23

3.6

4.1

—

Other diseases of pericardium

4.40

12.17

4.0

3.6

—

Fracture of rib(s), sternum and thoracic spine

142

742

1.92

12.13

4.0

3.9

—

Tumor necrosis factor alpha inhibitors

212

2.80

12.11

3.6

4.7

—

Abnormal weight loss

196

2.88

12.10

4.0

4.1

—

Other pulmonary heart/vessel disease

101

3.72

11.96

3.8

3.4

—

Hypokalaemia

243

2.65

11.85

4.4

4.0

—

Sequelae of tuberculosis, including avohilmo

5.97

11.84

5.5

4.9

—

Eosinophilia

10.82

11.84

5.3

5.0

—

Other (seronegative) rheumatoid arthritis, wide

394

2.27

11.83

4.3

3.8

—

Other diseases of urinary system

350

1285

1.53

11.79

4.1

3.8

—

Dermatitis and eczema

392

1559

1.49

11.77

4.4

3.8

—

Care involving dialysis

131

3.31

11.76

3.6

4.1

—

Solid cancers, including Hilmo

282

1025

1.61

11.74

3.6

4.1

—

Other nutritional deficiencies

223

1225

1.67

11.65

3.5

4.1

—

Adalimumab

117

3.44

11.64

3.8

5.3

—

Diseases of pulp and periapical tissues and dental caries

251

776

1.66

11.63

4.1

3.7

—

Myocardial infarction, strict

188

756

1.77

11.56

3.6

3.8

—

Adjustment and management of implanted device

398

2.25

11.56

3.2

4.2

—

Hyperlipidaemia, other/unspecified

182

933

1.76

11.54

3.7

3.9

—

Caries of dentine, including avohilmo

287

917

1.60

11.53

4.0

3.9

—

Other complications of surgical and medical care, not elsewhere classified

153

3.09

11.53

6.2

4.1

—

Mental and behavioural disorders due to tobacco

143

3.17

11.50

4.7

4.3

—

Malignant neoplasm

279

1023

1.60

11.47

3.5

4.1

—

Respiratory tuberculosis, clinically confirmed

12.19

11.42

7.8

4.9

—

Malignant neoplasm

279

1025

1.60

11.39

3.5

4.1

—

Dental caries, including avohilmo

274

870

1.62

11.38

4.1

3.9

—

Obesity due to excess calories

161

894

1.81

11.38

3.5

4.2

—

Urticaria and erythema

124

633

1.96

11.35

4.0

—

Secondary right heart disease

3.79

11.32

4.0

3.5

—

Sequelae with surgical and medical care as external cause

100

473

2.13

11.31

3.4

3.8

—

Urinary track infection

154

404

1.91

11.28

4.3

—

GI-bleeding

153

839

1.83

11.28

3.8

—

Presence of other devices

109

524

2.06

11.27

3.3

3.5

—

Smoking dependency

145

3.13

11.24

4.7

4.2

—

Other hearing loss

138

709

1.89

11.24

4.4

3.8

—

Endocrine, nutritional and metabolic diseases

227

678

1.69

11.23

4.1

3.8

—

Pneumococcal septicemia

4.63

11.21

4.3

4.2

—

Other disorders of bladder

286

2.47

11.18

4.3

4.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

355

1520

1.50

11.18

3.8

3.9

—

Dental operations

232

713

1.68

11.14

4.1

3.7

—

Other bacterial intestinal infections

411

2.20

11.13

4.6

3.8

—

Other abnormal findings of blood chemistry

3.90

11.11

4.9

3.7

—

Other necrotizing vasculopathies

141

3.15

11.11

4.7

4.2

—

Cardiac murmurs and other cardiac sounds

3.88

11.05

6.3

3.3

—

Sequelae of tuberculosis

5.84

11.05

5.6

5.0

—

L01XE Protein kinase inhibitors

102

3.58

11.04

3.6

3.8

—

Candidiasis

252

2.55

11.04

4.9

4.1

—

Enterocolitis due to Clostridium difficile

241

2.59

10.99

5.4

3.8

—

Dorsopathies

328

1084

1.53

10.95

3.6

4.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

353

1496

1.49

10.88

3.7

3.9

—

Agranulocytosis

208

2.71

10.86

4.1

—

Cholelithiasis

312

1397

1.53

10.83

3.8

3.9

—

Cystic fibrosis with pulmonary manifestations

+∞

10.80

24.4

0.0

—

Ill-defined and unknown causes of mortality

267

2.49

10.79

3.4

3.8

—

Angina pectoris

215

856

1.67

10.77

3.6

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

160

2.96

10.71

3.1

5.0

—

Gastrointestinal diseases

161

437

1.85

10.70

4.9

3.5

—

Fibromyalgia

109

3.41

10.67

4.5

5.0

—

Diseases of pulp and periapical tissues, including avohilmo

352

1216

1.50

10.63

3.9

3.8

—

Diseases of the digestive system

194

1150

1.68

10.62

3.9

—

Open wound of head

216

1243

1.64

10.61

3.7

4.0

—

Allergic rhinitis

407

2.16

10.59

4.5

4.0

—

Paralytic ileus and intestinal obstruction

120

621

1.94

10.59

3.5

3.9

—

Secondary hypertension

3.67

10.57

4.0

4.1

—

Retention of urine

167

768

1.76

10.56

3.9

3.8

—

Other/unspecified dorsalgia

135

719

1.86

10.50

3.5

4.0

—

Type 2 diabetes, wide definition

295

1211

1.54

10.47

3.5

3.9

—

Nonhereditary hypogammaglobulinemia

16.58

10.43

5.6

4.7

—

Diabetes, varying definitions

339

1315

1.50

10.41

4.5

3.9

—

Mental and behavioural disorders due to psychoactive substance use

223

1268

1.61

10.36

3.5

4.1

—

Other diseases of the digestive system

149

834

1.79

10.32

3.8

3.7

—

Other ill-defined and unspecified causes of mortality

250

2.50

10.24

3.4

3.8

—

Noninfective enteritis and colitis

165

952

1.74

10.23

4.3

3.8

—

Dermatographic urticaria

3.83

10.21

3.8

3.9

—

Disorders of mineral metabolism

154

2.94

10.17

3.7

4.6

—

Diabetes mellitus

339

1317

1.49

10.15

4.5

3.9

—

Mycoses, including avohilmo

314

1601

1.49

10.10

4.8

3.8

—

Gout, strict definition

100

495

2.03

10.09

3.6

3.8

—

Mouth breathing

146

817

1.79

10.07

4.7

3.8

—

Other disorders of skin and subcutaneous tissue

276

1525

1.53

10.07

4.5

3.9

—

Solid cancers

270

1017

1.56

10.03

3.5

4.1

—

Other bacterial intestinal infections, including avohilmo

103

516

2.00

10.03

4.4

4.0

—

Bacterial intestinal infections, IBD co-morbidities

416

2.13

10.02

5.3

3.9

—

Glomerular diseases

397

2.15

9.99

3.8

4.1

—

Any event in cancer register

284

1079

1.54

9.98

3.6

4.0

—

Respiratory tuberculosis, not confirmed

3.60

9.95

6.0

3.6

—

Respiratory tuberculosis, not confirmed, including avohilmo

3.60

9.95

6.0

3.6

—

157

2.88

9.82

5.7

4.2

—

Nonsuppurative otitis media

260

2.34

9.82

5.4

3.9

—

Diseases of the ear and mastoid process

363

1242

1.47

9.82

4.7

3.7

—

Substance abuse

216

1254

1.60

9.82

3.5

4.1

—

Other headache syndromes

131

714

1.83

9.79

3.9

4.0

—

Polyarthrosis

405

2.08

9.79

4.1

4.0

—

Selective serotonin reuptake inhibitors

338

1186

1.48

9.77

3.9

4.0

—

Sicca syndrome [Sjögren]

131

3.08

9.77

4.6

4.7

—

Intracranial injury

219

1282

1.59

9.74

3.9

4.0

—

Valvular operations

274

2.39

9.74

3.1

4.4

—

Other necrotizing vasculopathies (FG)

111

3.28

9.72

5.2

4.1

—

Diseases of the musculoskeletal system and connective tissue

147

401

1.84

9.70

4.0

3.8

—

Depression medications

2.86

9.64

3.3

4.7

—

Non-small cell lung cancer, squamous, helper endpoint

138

3.01

9.59

3.3

3.5

—

Intestinal stricture

137

766

1.80

9.56

3.7

3.8

—

Pneumoconiosis due to asbestos and other mineral fibres

4.09

9.56

3.8

3.1

—

Neurological diseases

263

847

1.56

9.55

4.0

—

Polycystic ovarian syndrome, consortium definition

187

638

1.68

9.45

4.4

4.1

—

Soft tissue disorders

331

1147

1.48

9.44

3.6

3.9

—

Superficial injury of lower leg

487

2.00

9.41

3.5

4.1

—

Disorders of eyelid, lacrimal system and orbit

314

1564

1.47

9.38

4.1

3.9

—

Drug-induced osteoporosis

10.96

9.35

9.1

4.8

—

Dental caries

434

2.03

9.31

4.2

3.8

—

Eustachian salpingitis and obstruction

3.65

9.25

5.1

4.3

—

Drug-induced neutropenia

125

3.07

9.24

3.5

4.7

—

Personality disorders

370

2.14

9.23

3.7

3.9

—

Non-Hodgkin lymphoma, all

3.49

9.21

3.7

4.2

—

Other viral diseases

449

2.03

9.18

4.8

3.9

—

STROKE

176

706

1.68

9.16

3.6

3.9

—

Zoster [herpes zoster], including avohilmo

201

1215

1.60

9.14

4.8

3.9

—

Pneumonitis due to solids and liquids

204

2.57

9.13

3.6

3.8

—

Other or unspecified ileus, impaction or obstruction

426

2.05

9.06

3.4

3.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

320

1297

1.47

8.99

4.1

3.9

—

L04AC Interleukin inhibitors

3.56

8.94

3.7

4.8

—

Cardiomyopathy

323

2.21

8.93

3.5

4.4

—

Abnormal spermatozoa

337

2.18

8.90

3.6

—

Respiratory conditions due to other external agents

6.93

8.88

3.2

5.0

—

Volume depletion

213

2.51

8.85

4.1

3.8

—

Type 2 diabetes

327

1302

1.46

8.84

4.2

3.9

—

Hernia

316

1442

1.46

8.84

4.0

—

Type 2 diabetes, definitions combined

323

1290

1.46

8.84

3.9

—

Meniscus derangement

200

825

1.61

8.83

4.6

3.7

—

Herpesviral [herpes simplex] infections

184

2.62

8.82

4.3

3.8

—

Caries of dentine

395

2.06

8.80

4.3

3.6

—

Symptoms and signs involving speech and voice

134

764

1.76

8.80

3.8

3.9

—

Voice disturbances

107

570

1.88

8.77

3.8

4.1

—

Disorders of sclera, cornea, iris and ciliary body

189

1181

1.60

8.76

4.3

3.9

—

Chronic nephritic syndrome

3.89

8.70

3.4

4.3

—

Hyperkalaemia

135

2.92

8.70

4.2

3.6

—

Type 2 diabetes, strict (exclude DM1)

325

1304

1.45

8.70

3.8

4.0

—

Other and unspecified immunodeficiencies with predominantly antibody defects

11.88

8.62

4.9

5.0

—

Viral hepatitis, IBD co-morbidity

4.78

8.58

2.8

3.9

—

Etanercept

3.52

8.52

3.5

5.4

—

Other diseases of anus and rectum

125

703

1.78

8.50

4.1

—

Obesity and other hyperalimentation

198

1183

1.58

8.47

3.5

4.1

—

Haemorrhage, not elsewhere classified

3.50

8.38

4.3

3.6

—

ILD medications: pirfenidone

11.10

8.36

5.9

2.8

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

101

537

1.89

8.36

3.4

3.8

—

Other and unspecified disorders of white blood cells

3.77

8.35

3.7

4.1

—

Congenital malformations of the respiratory system, including avohilmo

8.66

8.33

4.0

6.8

—

Deforming dorsopathies

100

530

1.89

8.33

4.1

4.4

—

Nasal polyp

386

2.06

8.33

4.5

3.8

—

Obesity

196

1175

1.57

8.32

3.5

4.1

—

Other infectious diseases

150

2.76

8.28

4.1

3.7

—

Dermatitis due to substances taken internally

3.44

8.22

6.2

4.1

—

Secondary uncertain malignant neoplasm

277

2.25

8.21

3.2

4.5

—

Acute pharyngitis

138

2.81

8.18

6.5

3.7

—

Other and unspecified effects of external causes

457

1.95

8.16

4.1

4.0

—

Extracorporeal dialysis

124

2.93

8.13

2.9

3.9

—

Selective deficiency of immunoglobulin G [IgG] subclasses

22.88

8.08

4.2

6.8

—

Aortic aneurysm

121

674

1.77

8.07

3.3

3.9

—

Injuries to the hip and thigh

197

1134

1.56

8.05

3.6

3.9

—

Polymyalgia rheumatica

312

2.16

8.03

3.9

4.0

—

Any mental disorder

366

1306

1.40

8.00

3.9

—

Osteonecrosis

3.16

7.95

3.3

4.1

—

Excessive earwax

241

1469

1.49

7.94

4.3

3.9

—

Coxarthrosis [arthrosis of hip](FG)

207

919

1.55

7.93

3.5

3.9

—

Disorders of lacrimal system

160

969

1.63

7.91

5.3

4.0

—

External causes of morbidity and mortality

207

660

1.57

7.89

4.0

—

Respiratory disorders in diseases classified elsewhere

8.65

7.86

3.4

5.5

—

Lymphoid leukaemia

122

2.90

7.75

3.5

3.9

—

Other disorders of lacrimal gland

133

786

1.70

7.74

5.6

3.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

322

1524

1.41

7.70

4.1

3.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

184

785

1.58

7.68

3.9

4.0

—

Hypothyroidism (congenital or acquired)

2.71

7.67

4.5

4.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

145

2.71

7.66

6.2

3.8

—

Anxiety disorders, excluding more controls

254

1099

1.48

7.65

3.9

4.0

—

Urticaria

497

1.88

7.60

4.1

3.9

—

Other dorsopathies, not elsewhere classified

300

1083

1.44

7.60

3.6

4.0

—

Other abnormal uterine and vaginal bleeding

252

2.09

7.57

3.9

4.3

—

Other viral diseases, including avohilmo

105

578

1.80

7.55

4.6

3.9

—

Nephropathy related operations

249

2.26

7.54

3.5

4.3

—

Other joint disorders

259

914

1.48

7.53

4.4

3.9

—

Diabetes, insulin treatment (Kela reimbursement)

339

1444

1.40

7.50

4.1

3.9

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

152

924

1.63

7.50

3.6

3.9

—

Adverse effects, not elsewhere classified

321

2.09

7.48

4.5

4.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

220

1447

1.49

7.46

4.0

3.9

—

Psychiatric diseases

325

1151

1.42

7.46

4.0

3.9

—

Postzoster neuralgia

6.58

7.45

3.7

3.5

—

Cystic fibrosis with intestinal manifestations

+∞

7.45

27.7

0.0

—

Non-small cell lung cancer, adenocarcinoma

136

2.74

7.44

2.8

4.2

—

Glomerulonephritis

189

2.45

7.40

3.9

3.8

—

Type 2 diabetes, definitions combined, including avohilmo

314

1287

1.41

7.32

3.9

4.0

—

Insulin medication

222

1238

1.49

7.29

4.4

3.8

—

Cardiomyopathies, Primary/intrinsic

221

2.32

7.29

3.4

4.4

—

Disorders of plasma-protein metabolism, not elsewhere classified

16.31

7.29

6.4

2.4

—

Alzheimer’s disease, strict definition

705

0.40

7.24

2.8

3.7

—

Hypothyroidism and >3 levothyroxin purchases

2.65

7.24

4.5

4.7

—

Hypothyroidism, levothyroxine purchases

2.65

7.24

4.5

4.7

—

Dialysis, with operation codes

254

2.22

7.20

3.6

4.3

—

Atopic dermatitis, strict definition with reimbursement

358

1.99

7.18

6.3

3.7

—

Ulcerative colitis, NAS

229

2.28

7.17

3.9

—

Antihypertensive medication - note that there are other indications

121

359

1.76

7.16

3.7

3.9

—

Insulin, fast-acting

131

789

1.66

7.12

5.0

3.9

—

Disorders of calcium metabolism

106

2.95

7.12

2.9

4.1

—

Emotionally unstable personality disorder

106

2.93

7.10

4.4

4.1

—

Pain (limb, back, neck, head abdominally)

224

746

1.51

7.08

3.9

3.8

—

Cardiomyopathy (excluding other)

224

2.29

7.08

3.4

4.1

—

Other infectious diseases, including avohilmo

181

2.45

7.07

4.1

3.7

—

Internal derangement of knee

125

738

1.68

7.06

3.8

3.9

—

Somatoform disorder

269

2.16

7.06

2.8

3.8

—

Viral and other specified intestinal infections

262

2.17

7.05

4.7

3.7

—

Malignant neoplasm of skin, including Hilmo

192

839

1.54

7.03

3.8

4.0

—

Disorders of adult personality and behaviour

384

1.96

7.00

4.1

—

Disorders of choroid and retina

296

1475

1.41

7.00

4.4

3.9

—

Arthrosis

234

866

1.48

6.99

4.0

3.8

—

Neoplasms

196

668

1.54

6.95

4.0

3.9

—

Other CVD

535

1.80

6.92

4.5

3.9

—

Arthropathies

262

914

1.45

6.89

4.1

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

332

2.03

6.88

3.2

4.3

—

Endocrine disorders, other/unspecified

6.19

6.80

3.4

4.5

—

Malnutrition

6.17

6.79

2.6

5.0

—

Dizziness and giddiness

261

1426

1.42

6.78

4.2

3.9

—

Zoster [herpes zoster]

431

1.89

6.78

5.5

3.7

—

Spondyloarthritis

334

2.01

6.77

3.3

3.9

—

Kidney transplant status

3.23

6.70

2.7

4.7

—

Shoulder lesions

257

1073

1.44

6.69

3.7

3.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

112

660

1.70

6.66

3.9

4.0

—

Other and unspecified tonsillitis

276

2.02

6.64

4.1

3.7

—

Vasomotor rhinitis (mode)

116

2.78

6.63

4.7

4.4

—

Alzheimer’s disease (Late onset)

679

0.41

6.63

2.8

3.7

—

Other diseases of pancreas

181

2.39

6.61

4.1

4.4

—

Hypotension

485

1.82

6.61

4.3

3.8

—

Kyphosis

8.85

6.58

4.6

3.0

—

Protein-energy malnutrition of moderate and mild degree

10.30

6.58

2.8

7.1

—

Polypectomy (DHB20)

128

2.68

6.57

5.6

3.9

—

Inflammatory bowel disease

105

611

1.72

6.55

4.2

3.9

—

Fall on same level

349

1367

1.36

6.53

4.2

3.9

—

Diseases of oral cavity, salivary glands and jaws

208

716

1.50

6.51

4.1

3.7

—

Unspecified fall

180

1173

1.51

6.49

4.0

—

Coxarthrosis

188

802

1.52

6.48

3.5

3.8

—

Other metabolic disorders

195

2.32

6.47

4.2

—

Diseases of the eye and adnexa

200

664

1.51

6.46

3.9

3.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

174

771

1.53

6.41

4.0

4.1

—

Insulin, fast-acting or short human

131

812

1.62

6.41

5.0

3.8

—

Disorders of parathyroid gland

434

1.85

6.40

3.7

3.8

—

Sciatica+with lumbago

161

924

1.54

6.40

3.9

4.0

—

Cutaneous abscess, furuncle and carbuncle

512

1.78

6.39

3.3

4.1

—

Cervical disc disorders

123

752

1.64

6.38

3.7

4.0

—

Delirium, not induced by alcohol and other psychoactive substances

341

1.97

6.38

3.4

3.7

—

Hypoparathyroidism

3.76

6.37

3.7

4.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

158

1016

1.54

6.37

3.3

3.9

—

Wegener granulomatosis

6.66

6.37

2.9

5.4

—

Peripheral artery disease

188

993

1.50

6.37

3.6

3.9

—

Keratitis

122

745

1.64

6.36

4.8

3.9

—

Myocarditis

4.07

6.35

3.4

—

Glomerular disorders in diseases classified elsewhere

242

2.16

6.33

3.6

3.8

—

180

1079

1.50

6.33

3.8

—

Other external causes of accidental injury

249

868

1.44

6.32

3.8

4.0

—

Injury, poisoning and certain other consequences of external causes

159

504

1.58

6.32

4.3

4.4

—

Injury of other and unspecified intrathoracic organs

125

2.66

6.31

3.9

—

Mental and behavioural disorders due to opioids

5.53

6.30

3.2

4.8

—

Alzheimer disease, including avohilmo

898

0.54

6.29

3.4

3.7

—

In situ neoplasms

151

974

1.55

6.27

3.8

3.9

—

Other and unspecified drugs and medicaments

143

2.53

6.26

6.6

4.2

—

Anxiety disorders

260

1267

1.41

6.26

3.9

4.0

—

Congenital malformations of the respiratory system

7.12

6.24

4.0

6.8

—

Other viral diseases, not elsewhere classified

289

2.04

6.22

4.9

4.1

—

Hernia of abdominal wall

166

1096

1.52

6.20

3.4

3.9

—

Use of anticholinesterases

923

0.52

6.20

3.2

3.7

—

N06DA Anticholinesterases

923

0.52

6.20

3.2

3.7

—

Falls/tendency to fall

321

1174

1.37

6.20

4.0

3.9

—

Crohn disease

193

2.29

6.17

3.4

3.9

—

Abnormal findings on examination of urine, without diagnosis

3.15

6.17

2.6

3.6

—

Mental and behavioural disorders due to alcohol

177

1130

1.49

6.10

3.3

3.9

—

Acute laryngitis and tracheitis

3.12

6.10

6.9

3.8

—

Seronegative rheumatoid arthritis

207

2.23

6.09

3.8

4.2

—

Other retinal disorders

245

1320

1.41

6.08

4.6

3.8

—

Adult respiratory distress syndrome

6.83

6.07

2.9

5.6

—

Open wound of forearm

182

2.32

6.07

3.5

4.2

—

Personal history of certain other diseases

10.12

6.04

5.8

4.8

—

Sequelae of infectious and parasitic diseases

128

2.59

6.04

5.6

3.5

—

Sequelae of infectious and parasitic diseases, including avohilmo

134

2.55

6.02

5.5

3.5

—

Alcohol withdrawal state with delirium

140

2.52

6.02

2.5

3.8

—

Other and unspecified rosacea

146

2.48

6.01

3.9

4.6

—

Diverticular disease of intestine

252

1114

1.41

6.01

3.8

4.0

—

Pollen allergy

180

2.31

6.00

3.9

4.4

—

Thoracic aortic aneurysm

357

1.91

5.99

3.3

3.8

—

Neurological diseases, wide definition

136

2.14

5.98

5.2

3.6

—

Type of accident

102

605

1.69

5.98

4.0

—

Other intervertebral disc disorders

249

1052

1.41

5.96

3.9

—

Hypothyroidism, strict autoimmune

220

1004

1.44

5.94

4.1

3.9

—

Diseases of liver

127

799

1.59

5.91

4.1

3.9

—

Mood disorders, excluding more controls

294

1261

1.37

5.90

3.7

4.0

—

Artrosis, including avohilmo

268

1053

1.39

5.88

3.7

3.9

—

Alcohol use disorder, ICD-based

144

934

1.55

5.87

3.2

3.9

—

Nonsuppurative otitis media, including avohilmo

407

1.79

5.86

5.2

3.7

—

Ankylosing spondylitis

142

2.48

5.85

4.1

3.8

—

Neurotic, stress-related and somatoform disorders

255

1261

1.39

5.82

3.9

4.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

201

1394

1.44

5.81

4.0

—

Other spirochaetal diseases

749

0.43

5.80

4.0

4.1

—

Cystitis

271

1165

1.38

5.79

4.5

3.9

—

Spirochaetal infections, other/unspecified, including avohilmo

748

0.43

5.79

4.0

4.1

—

Heartburn

199

2.22

5.77

3.0

4.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

222

1425

1.41

5.75

4.4

3.8

—

Actinic keratosis

168

1027

1.49

5.73

3.7

3.8

—

Abnormal involuntary movements

259

2.06

5.72

3.4

4.4

—

conjunctival haemorrhage

156

2.39

5.71

4.2

4.0

—

Lyme disease, including avohilmo

743

0.43

5.70

4.0

4.1

—

Lyme disease

743

0.43

5.70

4.0

4.1

—

Other spirochaetal diseases, including avohilmo

757

0.43

5.70

4.0

4.1

—

Symptoms and signs involving the skin and subcutaneous tissue

237

1606

1.39

5.69

4.1

3.9

—

Hypopituitarism

103

2.73

5.68

4.2

4.5

—

Persons encountering health services for examination and investigation

202

693

1.46

5.67

4.5

3.6

—

Non-follicular lymphoma

227

2.13

5.66

2.9

4.0

—

Acute and transient psychotic disorders

169

2.32

5.66

3.7

4.4

—

Presence of cardiac and vascular implants and grafts

158

768

1.52

5.65

3.2

3.6

—

ILD medications: acetylcysteine

13.14

5.61

6.3

3.4

—

Generalized skin eruption due to drugs and medicaments

3.42

5.59

7.0

4.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

217

1202

1.42

5.58

3.6

3.9

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

3.29

5.58

2.6

4.3

—

Dental pulpitis, including avohilmo

259

1201

1.38

5.57

4.2

4.0

—

Mental and behavioural disorders due to sedatives or hypnotics

2.94

5.57

3.0

4.7

—

Radiculopathy

345

1.89

5.56

3.9

4.1

—

Schizophrenia or delusion, excluding more controls

476

1.75

5.55

3.2

3.8

—

Vasculitis limited to skin, not elsewhere classified

3.85

5.55

4.3

3.3

—

Non-allergic asthma

140

2.44

5.52

2.9

4.2

—

Skin changes due to chronic exposure to nonionizing radiation

170

1046

1.47

5.50

3.7

3.8

—

103

584

1.65

5.50

3.8

3.9

—

Nerve, nerve root and plexus disorders

346

1574

1.32

5.50

3.7

3.9

—

Diabetes medication

326

1429

1.33

5.49

4.3

3.9

—

Rare circulating lymphoid malignancy, including Hilmo

4.65

5.49

4.0

4.8

—

Accidents

243

868

1.40

5.47

3.8

4.0

—

Diseases of middle ear and mastoid

158

862

1.50

5.46

4.8

3.9

—

Alzheimer disease

813

0.54

5.46

3.3

3.7

—

Corneal ulcer

341

1.88

5.42

3.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

2.84

5.42

3.4

3.8

—

Vitamin deficiency, wide

2.97

5.42

4.3

—

Vitamin deficiency

2.97

5.42

4.3

—

Haemorrhoids and perianal venous thrombosis

125

795

1.56

5.41

4.4

4.1

—

Artificial opening status

2.83

5.41

4.4

3.2

—

Specific personality disorders

313

1.92

5.41

4.0

3.8

—

Intussusception

5.24

5.41

4.5

5.2

—

Infections of the skin and subcutaneous tissue

182

1241

1.44

5.38

3.9

4.0

—

Acute pancreatitis

458

1.75

5.37

3.5

4.0

—

Malignant neoplasm of skin

178

823

1.47

5.36

3.9

4.0

—

139

782

1.53

5.35

3.8

—

Other diseases of intestine

357

1.86

5.34

4.0

3.9

—

Use of donepezil

622

0.41

5.34

3.0

3.8

—

Myocardial infarction, without ST-elevation

173

1072

1.46

5.32

3.7

3.8

—

Congenital malformations of trachea and bronchus

9.31

5.32

4.7

7.5

—

Spondylopathies (FG)

200

2.16

5.29

3.7

4.5

—

Benign neoplasm: Bronchus and lung

6.80

5.28

6.7

5.7

—

Basal cell carcinoma, including Hilmo

168

771

1.48

5.28

3.9

4.1

—

Other symptoms and signs involving the digestive system and abdomen

295

1.94

5.27

4.6

4.0

—

Mood disorders

308

1480

1.33

5.25

3.7

4.1

—

Rosacea

214

2.11

5.25

3.8

4.4

—

Superficial injury of hip and thigh

352

1.85

5.24

3.7

4.1

—

D07AA Corticosteroids, weak (group I)

207

2.13

5.24

3.6

4.7

—

Other abnormal immunological findings in serum

5.99

5.23

5.7

5.5

—

Benign neoplasm: Tongue

3.68

5.21

4.6

4.2

—

Polyarthritis, unspecified

3.50

5.18

3.1

3.5

—

Pulmonary eosinophilia, not elsewhere classified

7.49

5.17

3.1

6.1

—

Other gastritis (incl. Duodenitis)

509

1.69

5.15

3.9

3.8

—

Other specific joint derangements/joint disorders

198

865

1.43

5.14

3.9

4.0

—

Scoliosis

109

2.58

5.12

3.9

4.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

175

950

1.45

5.12

3.6

3.9

—

Postmenopausal osteoporosis with pathological fracture

121

2.50

5.12

3.0

4.6

—

Alcohol dependence

586

1.64

5.11

3.1

4.0

—

Gonarthrosis [arthrosis of knee](FG)

239

996

1.38

5.09

4.2

3.8

—

Hypersensitivity pneumonitis due to organic dust

5.75

5.09

5.2

5.4

—

Tobacco use

2.86

5.08

3.3

4.2

—

Diffuse large B-cell lymphoma

2.78

5.04

3.0

4.2

—

Diffuse large B-cell lymphoma, including Hilmo

2.78

5.04

3.0

4.2

—

Diffuse large B-cell lymphoma, helper endpoint

2.78

5.04

3.0

4.2

—

Other noninfective gastroenteritis and colitis

504

1.69

5.04

4.2

3.8

—

Vulvovaginal ulceration/inflammation in other diseases

3.18

5.03

3.1

5.0

—

Coagulation defects, purpura and other haemorrhagic conditions

408

1.77

5.03

4.1

—

Abnormal findings on diagnostic imaging of other body structures

218

2.07

5.01

3.8

3.7

—

Other disorders of kidney and ureter

294

1.91

5.00

4.8

4.0

—

Acute generalized exanthematous pustulosis

2.98

4.99

6.8

4.1

—

Assault

141

2.35

4.97

2.7

4.7

—

Carcinoma in situ of skin of other and unspecified parts of face

247

2.00

4.93

3.6

3.7

—

Mood [affective] disorders

305

1482

1.32

4.90

3.8

4.0

—

Acute pancreatitis (for exclusion)

471

1.70

4.90

3.5

3.9

—

Amenorrhoea

3.49

4.89

4.9

4.3

—

Inflammatory bowel disease, strict (require KELA)

376

1.79

4.85

4.7

3.8

—

Superficial injury of abdomen, lower back and pelvis

290

1.90

4.85

3.7

4.3

—

Paracetamol or NSAID medication

105

2.17

4.83

5.3

3.8

—

Fibrosis and cirrhosis of liver

156

2.26

4.82

3.7

4.0

—

Basal cell carcinoma

160

748

1.46

4.79

4.0

—

Other endocrine disorders

3.10

4.79

3.8

5.4

—

Alcohol use disorder, Swedish definition

188

1218

1.40

4.77

3.2

3.9

—

Disorders of skin appendages

139

934

1.48

4.76

3.8

4.0

—

Acute bronchiolitis

4.53

4.76

3.1

7.2

—

Tuberculosis of other organs, strict

4.47

4.76

2.7

4.6

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

170

2.19

4.75

2.8

3.7

—

Pain in joint

164

693

1.46

4.74

3.9

—

Viral and other specified intestinal infections, including avohilmo

385

1.75

4.74

4.6

3.7

—

Giant cell arteritis

2.81

4.72

5.4

3.9

—

Unspecified kidney failure

259

1.94

4.67

3.2

3.8

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

298

1.87

4.66

3.1

4.1

—

IBD patients in KELA-register

381

1.76

4.66

4.7

3.7

—

Use of biperiden

2.86

4.66

2.7

4.5

—

Other abnormal findings in urine

5.08

4.65

2.8

4.8

—

Other disorders of conjunctiva

316

1.84

4.65

4.4

3.8

—

Tuberculosis of other organs, strict, including avohilmo

4.34

4.64

2.7

4.7

—

Other specified/unspecified disorders of bone/cartilage

5.05

4.64

3.1

4.3

—

202

1273

1.38

4.63

3.2

4.0

—

Chronic ulcer of skin, not elsewhere classified

146

2.27

4.63

4.3

3.4

—

Convulsions, not elsewhere classified

355

1.78

4.63

3.2

4.1

—

Ventral hernia

548

1.63

4.62

3.4

3.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

246

1.96

4.61

5.3

4.0

—

Diabetic nephropathy, excluding more controls

232

1.90

4.61

3.3

3.9

—

Other neurological diseases

256

1490

1.33

4.61

3.7

4.0

—

Hyperparathyroidism

371

1.76

4.59

3.8

—

Acute drug-induced interstitial lung disorder

8.41

4.59

3.3

7.3

—

Degenerative diseases of the nervous system

893

0.60

4.58

3.5

3.8

—

Crohn's disease NAS

2.69

4.58

3.3

4.4

—

Unspecified nephritic syndrome

4.57

3.0

4.5

—

Common variable immunodeficiency

10.30

4.55

5.2

5.9

—

Other enthesopathies

558

1.62

4.54

3.6

4.3

—

Deviated nasal septum

102

652

1.57

4.52

5.7

3.5

—

Missing teeth due to accident, extraction or parodontitis

218

1437

1.36

4.49

4.0

3.9

—

Other diseases of blood and blood-forming organs

123

2.37

4.48

2.8

3.7

—

Chronic periodontitis, including avohilmo

315

1553

1.29

4.47

3.8

4.0

—

Psoriasis (vulgaris), strict definition

3.29

4.47

3.8

4.4

—

Unspecific neurodegenerative disorder

1005

0.64

4.46

3.4

3.8

—

Disorders of synovium and tendon

158

937

1.43

4.45

4.4

4.1

—

Tuberculosis of other organs

4.43

4.45

2.5

4.3

—

Periodontitis

315

1553

1.29

4.44

3.8

4.0

—

Fentanyl

208

2.02

4.43

3.5

4.0

—

Other and unspecified vasculitis limited to skin

4.10

4.42

4.1

3.4

—

Lumbar disc prolapse

187

996

1.39

4.40

3.7

3.9

—

Hypertensive heart and/or renal disease

100

463

1.58

4.40

3.8

4.0

—

Essential (haemorrhagic) thrombocythaemia

3.02

4.40

2.7

4.6

—

Transient ischemic attack

198

1148

1.38

4.39

3.8

3.9

—

Injuries to the elbow and forearm

211

1332

1.36

4.38

4.2

4.0

—

Intercostal neuropathy

7.69

4.38

2.2

4.7

—

Nonischemic cardiomyopathy

189

2.07

4.38

4.1

3.8

—

Medical observation and evaluation for suspected diseases and conditions

190

693

1.40

4.38

4.5

3.6

—

Hypothyroidism, drug reimbursement

2.56

4.37

4.0

5.1

—

Heterophoria

100

2.51

4.37

4.0

5.0

—

Other skin changes

472

1.66

4.36

4.0

3.9

—

Ulcerative ileocolitis

3.11

4.36

6.4

4.5

—

Ulcerative colitis

457

1.67

4.35

4.5

3.8

—

Other sleep disorders

190

2.06

4.33

5.0

3.9

—

Pyogenic arthritis

119

2.37

4.32

3.5

—

Injuries to the shoulder and upper arm

275

1625

1.31

4.31

3.6

4.0

—

Chronic pancreatitis

267

1.88

4.29

5.9

4.2

—

Artificial joint operation, meniscal resection

307

1522

1.29

4.28

4.3

3.8

—

Use of memantine

756

0.56

4.28

3.5

3.7

—

Use of other anti-dementia drugs

756

0.56

4.28

3.5

3.7

—

Other viral diseases, not elsewhere classified, including avohilmo

419

1.69

4.26

4.6

3.9

—

Entropion and trichiasis of eyelid

219

1.97

4.25

3.6

3.7

—

Cholecystitis

333

1.78

4.25

3.2

4.1

—

Other salmonella infections

3.06

4.24

5.8

3.8

—

Necrosis of pulp, including avohilmo

161

1131

1.41

4.24

5.0

3.9

—

Other diseases of oesophagus

226

1.96

4.24

4.3

3.9

—

DVT of lower extremities

438

1.67

4.23

2.9

3.7

—

Disorders of oesophagus in diseases classified elsewhere

3.90

4.21

4.1

4.3

—

Disorders of magnesium metabolism

7.10

4.19

5.1

2.7

—

Cirrhosis of liver, NAS

115

2.36

4.16

3.4

3.8

—

Superficial injury of thorax

306

1.80

4.16

3.3

3.9

—

Idiopathic gout

242

1.91

4.15

3.8

—

Purpura and other haemorrhagic conditions

285

1.83

4.13

4.1

—

Depression

272

1396

1.30

4.13

3.7

4.0

—

192

1259

1.36

4.12

3.2

3.9

—

Disorders of speech understanding and production

4.06

4.12

4.1

7.5

—

Disorders of conjunctiva

237

1388

1.32

4.11

4.1

4.0

—

8.31

4.10

4.4

7.7

—

Ulcerative colitis (strict definition, require KELA)

257

1.87

4.10

5.3

4.0

—

Herpesviral [herpes simplex] infections, including avohilmo

435

1.66

4.07

4.2

4.1

—

Other abnormalities of plasma proteins

4.69

4.07

5.5

4.9

—

Varicella [chickenpox], including avohilmo

2.87

4.05

2.9

5.9

—

Kela-code for severe mental illness

100

655

1.53

4.04

3.1

4.0

—

Soft tissue disorders related to use, overuse and pressure

568

1.57

4.04

4.7

4.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

280

1.83

4.03

5.1

3.9

—

Carcinoma in situ of skin, other sites/unspecified

4.27

4.03

3.8

4.9

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

543

1.57

4.02

3.1

4.1

—

Disorders of muscles

189

2.02

4.02

5.6

5.0

—

Other bacterial agents as the cause of diseases classified to other chapters

6.55

4.00

9.1

7.1

—

Fracture of lumbar spine and pelvis

545

1.58

3.99

3.3

3.8

—

Brachial plexus disorders

111

2.35

3.99

3.1

4.0

—

Ankylosing spondylitis, ICD10

143

2.18

3.98

4.1

3.8

—

Viral warts, including avohilmo

355

1.72

3.97

4.3

4.1

—

Other specified disorders of kidney and ureter

3.04

3.97

5.1

4.0

—

Preterm labour and delivery

348

1.73

3.95

4.6

4.4

—

Fracture of femur

113

687

1.49

3.93

3.5

3.9

—

Other viral hepatitis

2.73

3.92

2.8

4.4

—

Psoriatic and enteropathic arthropathies

191

2.00

3.91

3.8

4.1

—

Rotator cuff syndrome

202

1033

1.35

3.91

3.9

—

Urethral stricture

151

2.13

3.90

4.0

3.6

—

ILD and respiratory illness in diseases classified elsewhere

7.52

3.90

4.4

7.3

—

Ischaemic Stroke, excluding all haemorrhages

212

1170

1.34

3.89

3.7

3.8

—

Other viral hepatitis, including avohilmo

2.64

3.89

2.8

4.2

—

Genitourinary diseases

154

544

1.42

3.86

3.8

—

Benign neoplasm: Pancreas

2.99

3.86

6.1

4.2

—

Peritonsillar abscess

263

1.83

3.83

3.1

3.6

—

Other condition

256

1.84

3.83

4.6

4.4

—

Dialysis

2.70

3.83

2.7

4.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

129

892

1.44

3.83

3.9

—

Other immunodeficiencies

8.87

3.78

9.6

3.0

—

Menorrhagia

271

1.63

3.78

4.4

4.2

—

Personal history of allergy to analgesic agent

12.25

3.78

3.0

12.0

—

Degeneration of macula and posterior pole

191

1096

1.35

3.76

4.3

3.7

—

Other superficial mycoses

4.62

3.75

4.3

—

Glaucoma

210

1349

1.32

3.73

4.0

3.8

—

Ulcerative rectosigmoiditis

121

2.24

3.73

4.1

3.8

—

Benign neoplasms

288

1225

1.28

3.73

4.6

3.8

—

Cholecystectomy

228

1483

1.31

3.70

3.8

3.9

—

Corticotropin deficiency

6.80

3.69

3.9

6.4

—

Mantle cell lymphoma

6.79

3.69

3.6

5.2

—

Abnormal findings on diagnostic imaging of central nervous system

3.01

3.69

4.4

4.9

—

Acute epiglottitis

6.74

3.68

3.7

5.8

—

Other disorders involving the immune mechanism, not elsewhere classified

3.13

3.65

3.5

4.8

—

Exclusions for E4_PCOS_CONSORTIUM

173

790

1.37

3.65

4.0

4.1

—

Papulosquamous disorders

124

868

1.43

3.65

3.8

4.0

—

Need for other prophylactic measures

2.43

3.64

3.4

4.3

—

Hypercalcemia

2.55

3.63

2.8

4.3

—

Abdominal aortic aneurysm (AAA)

295

1.76

3.63

3.4

3.5

—

Disorders of thyroid, IBD co-morbidities

117

2.05

3.63

4.0

3.7

—

Gastroduodenal ulcer

101

678

1.49

3.63

3.6

3.8

—

Varicella [chickenpox]

2.87

3.63

2.9

6.1

—

Umbilical hernia

584

1.53

3.62

3.4

3.6

—

Gonarthrosis

200

846

1.34

3.59

4.3

3.8

—

Primary open-angle glaucoma, strict

106

721

1.47

3.58

3.9

3.8

—

Inflammatory diseases of female pelvic organs

142

692

1.41

3.58

4.0

4.2

—

Disorders of parathyroid gland, other and/or unspecified

7.96

3.58

3.6

6.6

—

Anuria and oliguria

7.95

3.58

4.3

7.8

—

Pyoderma gangrenosum

7.93

3.57

6.0

7.6

—

Ankylosing spondylitis, strict definition

2.96

3.57

3.5

4.2

—

Iridocyclitis

467

1.59

3.57

3.4

4.0

—

Viral hepatitis, including avohilmo

2.40

3.55

3.0

3.9

—

Unspecified mental disorder

106

725

1.46

3.53

3.0

4.0

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

5.37

3.52

9.1

6.2

—

Schizophrenia, schizotypal and delusional disorders

556

1.53

3.51

3.2

4.0

—

Other and unspecified psoriasis

125

2.17

3.48

4.0

3.9

—

Acute and subacute iridocyclitis

385

1.64

3.47

3.5

4.0

—

Viral hepatitis

2.42

3.47

3.0

3.9

—

Scleritis and episcleritis

2.54

3.46

3.6

5.2

—

Acute suppurative otitis media

260

1.76

3.45

6.3

3.8

—

Schizophrenia or delusion

551

1.53

3.44

3.2

4.0

—

Cardiac arrest

2.45

3.43

3.6

4.0

—

Psoriasis vulgaris

371

1.65

3.43

3.2

4.0

—

Unstable angina pectoris

129

719

1.41

3.43

3.8

3.7

—

Chronic viral hepatitis

2.77

3.42

2.8

4.3

—

Alcohol abuse, main dg, excluding more controls

237

1.82

3.41

2.9

4.1

—

Recurrent or chronic depression

445

1.50

3.40

4.3

4.1

—

Other/unspecified cytomegaloviral diseases

4.12

3.40

2.5

5.8

—

Coxibs

337

1.51

3.40

3.9

4.0

—

Other arthrosis

165

815

1.36

3.40

3.6

3.8

—

Benign neoplasm of middle ear and respiratory system

167

1.99

3.38

4.4

4.0

—

Mantle cell lymphoma, including Hilmo

5.07

3.38

3.6

4.3

—

Polyarteritis nodosa and related conditions

5.07

3.38

3.0

6.0

—

Other nonthrombocytopenic purpura

7.11

3.38

3.3

8.2

—

Chorioretinal inflammation

3.12

3.37

3.2

4.3

—

Other and unspecified aplastic anaemias

7.09

3.37

3.1

7.7

—

Personal history of allergy to drugs, medicaments and biological substances

7.08

3.37

4.3

4.7

—

Polyuria

562

1.52

3.37

3.7

4.0

—

Disorders of continuity of bone

140

2.08

3.37

4.8

5.1

—

Benign neoplasm of other and unspecified endocrine glands

275

1.75

3.36

3.9

4.2

—

Hyperfunction of pituitary gland

2.84

3.36

4.1

3.9

—

Malignant neoplasm of endocrine gland

101

2.29

3.35

5.7

5.1

—

Other keratitis

175

1.95

3.32

3.6

4.1

—

Schizophrenia

232

1.81

3.32

2.7

4.1

—

Poisoning by drugs, medicaments and biological substances

344

1.66

3.31

3.6

4.1

—

Other salmonella infections, including avohilmo

2.63

3.30

5.8

3.7

—

Anterior Iridocyclitis

414

1.60

3.30

3.5

4.1

—

Cytomegalovirus infection, IBD co-morbidity

3.67

3.30

2.8

4.8

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

3.97

3.29

2.0

3.8

—

Dilated cardiomyopathy

277

1.74

3.29

3.1

4.1

—

Dissociative [conversion] disorders

3.65

3.29

2.7

4.9

—

Suppurative and unspecified otitis media

456

1.54

3.28

5.1

3.7

—

Familial hypercholesterolemia

377

1.62

3.25

3.4

4.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

2.79

3.24

7.7

6.1

—

Assault by bodily force

2.34

3.24

2.8

5.1

—

Specific development disorders of speech and language

2.79

3.23

4.3

5.9

—

Scabies

2.68

3.22

4.3

6.5

—

Other follicular disorders

103

2.24

3.22

4.3

4.1

—

Chronic suppurative otitis media, including avohilmo

136

2.07

3.21

3.8

4.6

—

Benign neoplasm: Parathyroid gland

5.42

3.20

3.5

6.7

—

Conjunctivitis (acute, non atopic)

494

1.53

3.20

4.0

3.9

—

Gastric ulcer

441

1.57

3.20

3.5

3.8

—

Other disorders of bone

317

1.68

3.20

3.5

4.1

—

Rash and other nonspecific skin eruption

171

1.94

3.18

4.3

—

Other epidermal thickening

2.42

3.14

3.4

—

Ocular pain

124

2.10

3.13

3.8

4.8

—

Other diseases of lip and oral mucosa

125

903

1.39

3.13

4.3

4.0

—

Acute peritonitis

131

2.07

3.12

3.2

4.2

—

Crohn's disease of small intestine

2.29

3.10

2.6

4.5

—

Malignant neoplasm of endocrine gland, including Hilmo

118

2.13

3.09

5.5

4.9

—

Malignant neoplasm of larynx, including Hilmo

3.70

3.09

4.1

—

Benign neoplasm: Adrenal gland

159

1.96

3.09

4.2

3.9

—

Calcific aortic valvular stenosis

124

863

1.39

3.08

3.2

3.8

—

Calcific aortic valvular stenosis, operated

124

863

1.39

3.08

3.2

3.8

—

Operations 2 for CAVS

124

863

1.39

3.08

3.2

3.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

124

863

1.39

3.08

3.2

3.8

—

Disturbances of skin sensation

477

1.53

3.08

4.4

4.0

—

Diseases of salivary glands

664

1.45

3.08

4.2

4.0

—

Malignant neoplasm of hypopharynx, including Hilmo

7.65

3.07

4.5

6.5

—

Spondylolisthesis/Spondylolysis

352

1.62

3.06

4.4

4.0

—

Other and unspecified epidermal thickening

3.20

3.06

3.3

3.4

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.19

3.06

3.5

4.7

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

268

1403

1.25

3.06

3.9

4.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

195

1.85

3.06

3.3

3.8

—

Calcific aortic valvular stenosis, including rheumatic fever

124

864

1.38

3.05

3.2

3.8

—

Total colectomy

2.60

3.04

5.3

4.3

—

Total colectomy operation

2.60

3.04

5.3

4.3

—

Explicit fungal Sepsis

5.96

3.04

5.4

7.2

—

Explicit fungal Sepsis, including avohilmo

5.96

3.04

5.4

7.2

—

Phlebitis and thrombophlebitis (not including DVT)

479

1.53

3.03

3.8

3.9

—

Malignant neoplasm of thyroid gland

2.27

3.03

6.1

5.2

—

Maltreatment syndromes

2.90

3.02

2.9

6.6

—

Contact with other hot fluids

3.35

3.02

8.0

5.1

—

Leisure time condition

369

1.60

3.02

4.1

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

10.38

3.00

4.4

7.8

—

Mature T/NK-cell lymphomas, hilmo

4.34

3.00

3.0

5.3

—

Cerebrovascular diseases

253

1398

1.26

3.00

3.6

3.9

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

218

1.79

3.00

5.8

4.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

365

1.60

3.00

3.3

4.1

—

Other dialysis

2.77

2.99

4.7

4.4

—

Defects in the complement system

10.16

2.99

3.4

3.0

—

Stroke, excluding SAH

214

1208

1.28

2.99

3.7

3.8

—

Occupational exposure to risk-factors

2.65

2.97

3.3

3.5

—

L01XX Other antineoplastic agents

134

2.03

2.96

3.7

—

Other (not insulin) diabetes medications

296

1408

1.23

2.94

3.6

3.9

—

Varicose veins

202

1188

1.29

2.94

4.0

—

Other/unspecified enthesopathies, not elsewhere classified

162

1.92

2.94

4.0

4.6

—

Follicular lymphoma, hilmo

2.29

2.94

3.6

4.6

—

Speech therapy

604

0.56

2.93

3.1

4.0

—

Failure and rejection of transplanted organs and tissues

4.76

2.93

7.8

3.3

—

Anaemia in chronic diseases classified elsewhere

2.85

2.92

3.9

4.2

—

Other diseases of biliary tract

191

1.84

2.92

2.9

4.5

—

Lesion of ulnar nerve

280

1.68

2.91

3.6

3.8

—

Alcohol-induced chronic pancreatitis

128

2.04

2.91

2.8

3.9

—

Hypothyroidism, other/unspecified

257

1353

1.25

2.91

4.0

3.9

—

IgA nephropathy (IgA glomerulonephritis)

3.47

2.90

3.5

5.3

—

Malignant neoplasm of larynx

4.13

2.89

3.9

4.1

—

Deficiency of other B group vitamins

3.73

2.88

4.6

4.9

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

5.47

2.88

5.9

6.3

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

5.45

2.88

7.7

6.8

—

Other diseases of liver

374

1.58

2.87

5.0

3.9

—

Papillary adenocarcinoma of thyroid gland

2.51

2.87

7.4

5.5

—

Irregular menses

459

1.46

2.86

4.7

4.1

—

Cytomegaloviral disease

3.19

2.85

2.8

5.2

—

Dermatophytosis

305

1.64

2.84

3.9

—

Chronic suppurative otitis media

109

2.12

2.84

3.9

3.6

—

Pain associated with micturition

245

1.72

2.82

3.2

4.7

—

Psoriasis

602

1.45

2.82

3.5

3.9

—

Excessive, frequent and irregular menstruation

280

1.51

2.81

4.1

—

Primary adrenocortical insufficiency

4.51

2.80

5.0

5.8

—

Pain in thoracic spine

268

1.68

2.80

3.8

4.0

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

4.50

2.80

4.5

5.0

—

Universal erythroderma, KELA reimbursement

4.49

2.80

3.9

5.3

—

Cardiomyopathy, other and unspecified

130

2.01

2.80

3.2

4.4

—

!Aliquae complicationes praecoces traumatis

2.41

2.80

4.2

4.1

—

Early complications of trauma

2.41

2.80

4.2

4.1

—

Vascular disorders of the intestines

165

1.89

2.80

4.1

3.9

—

Squamous cell neoplasms and carcinomas of the skin

238

1.73

2.80

3.0

4.3

—

Thrombocytopenia, unspecified

151

1.93

2.79

3.3

3.9

—

Inguinal hernia

192

993

1.29

2.78

4.2

3.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

307

1.63

2.78

4.9

3.9

—

Cytomegaloviral disease, including avohilmo

3.10

2.77

2.8

5.1

—

Other mycoses, not elsewhere classified/unspecified

8.57

2.77

14.4

6.7

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

402

1.55

2.75

3.5

4.3

—

Infective dermatitis

217

1.76

2.75

3.3

3.9

—

Left bundle-branch block

131

1.99

2.75

3.0

4.2

—

Other and unspecified injuries of lower leg

104

2.12

2.74

4.4

4.2

—

Allergic urticaria

104

2.12

2.74

4.5

4.3

—

Diseases of peritoneum

210

1.77

2.74

3.5

4.1

—

Primary open-angle glaucoma

121

857

1.36

2.74

3.9

3.8

—

Other diseases of hard tissues of teeth

176

699

1.31

2.73

4.6

3.7

—

Glaucoma suspect

126

934

1.35

2.73

4.1

3.8

—

malignant neoplasm of male genital organs, including Hilmo

106

453

1.41

2.73

3.7

3.9

—

Open wound of lower leg

301

1.63

2.73

5.6

4.2

—

Peripheral retinal degeneration

2.73

2.72

5.5

4.2

—

Otitis media, unspecified

108

2.05

2.71

6.4

3.5

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

6.09

2.71

3.5

7.9

—

Symptoms and signs involving appearance and behaviour

6.09

2.71

2.8

5.5

—

Folate deficiency anaemia

6.07

2.70

7.5

5.6

—

Episcleritis

2.51

2.70

3.7

4.6

—

Primary coxarthrosis, bilateral

106

767

1.38

2.69

3.7

3.9

—

Persistent mood disorders

341

1.59

2.69

3.9

4.1

—

Malignant neoplasm of heart, mediastinum and pleura

4.26

2.68

1.9

4.5

—

Osteonecrosis due to drugs

4.26

2.68

2.5

5.9

—

Complications following infusion, transfusion and therapeutic injection

4.25

2.68

2.6

4.6

—

Other disorders of the musculoskeletal system and connective tissue

318

1.61

2.68

3.3

4.0

—

Enteropathic arthropathies

3.78

2.67

3.0

3.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.77

2.67

3.0

5.2

—

Other strabismus

356

1.57

2.67

3.5

4.2

—

Superficial injury of head

477

1.49

2.67

3.2

4.1

—

Disorders of lipoprotein metabolism and other lipidaemias

246

1204

1.24

2.66

3.3

3.9

—

Carcinoma in situ of skin of scalp and neck

2.35

2.66

4.4

3.9

—

Maternal care for cervical incompetence

2.80

2.65

3.9

4.7

—

Other and unspecified nonorganic psychotic disorders

250

1.68

2.64

3.3

4.5

—

Gonarthrosis, primary, with knee surgery

209

1293

1.26

2.64

4.5

3.9

—

Malignant neoplasm of thyroid gland, including Hilmo

106

2.08

2.62

6.0

4.9

—

Stroke, including SAH

219

1255

1.25

2.62

3.6

3.9

—

Malignant neoplasm of mesothelium and soft tissue

2.47

2.62

2.1

4.1

—

Haemolytic anaemias

2.56

2.62

3.4

4.0

—

Tinnitus

480

1.48

2.61

5.9

3.8

—

Discitis, unspecified

3.37

2.61

2.4

3.1

—

Poisoning by medicine

297

1.62

2.61

3.7

4.2

—

Sequelae of other external causes

2.16

2.61

6.0

3.7

—

Other prurigo

4.72

2.60

4.6

6.5

—

Lifestyle-related condition

4.72

2.60

2.9

4.9

—

Other factor of the environment

4.72

2.60

2.9

4.9

—

Other disorders of cornea

184

1.80

2.60

6.5

4.2

—

Otitis externa, unspecified

184

1.80

2.60

3.7

4.2

—

Visual disturbances

146

1116

1.31

2.60

4.7

3.8

—

Oxicams

328

1.46

2.59

3.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

237

1284

1.24

2.58

4.0

—

Caries of enamel

176

1465

0.78

2.58

3.9

4.1

—

3.62

2.58

3.1

5.1

—

Hypertensive Renal Disease

2.20

2.57

3.2

3.5

—

Other anxiety disorders

598

1.40

2.57

4.8

4.1

—

Other disorders of veins

123

904

1.34

2.56

4.3

4.0

—

Syndrome of inappropriate secretion of antidiuretic hormone

7.28

2.56

6.8

6.4

—

Malignant neoplasm of nasal cavity and sinuses

7.25

2.56

2.2

6.9

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

5.53

2.55

2.5

4.6

—

Myositis

2.75

2.55

3.0

3.6

—

Spinal osteochondrosis

5.51

2.55

2.0

2.8

—

Use of rivastigmine

475

0.54

2.55

3.0

3.7

—

Raynaud syndrome

128

1.96

2.55

3.4

4.2

—

Nummular dermatitis

171

1.82

2.54

5.0

3.9

—

Contact with heat and hot substances

2.23

2.54

6.4

4.3

—

Other Crohn's disease

2.23

2.53

4.0

4.4

—

Atopic dermatitis, strict definition

347

1.55

2.51

5.6

3.8

—

Conjunctivitis

193

1232

1.26

2.51

4.0

4.1

—

Other peripheral vascular diseases

143

1.89

2.50

3.6

3.8

—

Hodgkin lymphoma, hilmo

2.99

2.49

3.4

4.4

—

Strabismus

484

1.47

2.49

3.3

4.0

—

Insulin, intermediate and long-acting

176

1338

1.27

2.48

3.9

3.8

—

Benign neoplasm of mouth and pharynx

217

1.71

2.48

3.6

4.4

—

Subjective visual disturbances

519

1.45

2.47

3.7

3.8

—

Adhesive capsulitis of shoulder

341

1.56

2.47

4.0

4.1

—

Unspecified visual impairment (binocular)

3.84

2.47

2.4

6.6

—

Visual disturbances and blindness

158

1229

1.29

2.46

4.7

3.9

—

Mental and behavioural disorders due to cannabinoids

3.83

2.46

3.0

4.3

—

Familial hypercholesterolemia, with ischemic heart disease

210

1.72

2.46

3.4

3.7

—

Postprocedural musculoskeletal disorders, not elsewhere classified

144

1.88

2.46

3.4

4.9

—

Nephrotic syndrome

2.68

2.45

4.7

4.5

—

Multiple myeloma, including Hilmo

2.15

2.45

3.7

4.5

—

Speech and linguistic disorders, excluding more controls

2.31

2.43

5.5

4.7

—

Any dementia

932

0.73

2.42

3.2

3.8

—

Secondary polycythaemia

2.92

2.42

2.5

3.7

—

SLE (Finngen)

2.91

2.41

3.7

4.2

—

Golimumab

2.91

2.41

2.6

4.3

—

Varicose veins of other sites

103

2.05

2.41

3.6

4.1

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.06

2.41

3.0

5.7

—

Benign neoplasm: Scapula and long bones of upper limb

5.06

2.41

3.8

6.6

—

Persons encountering health services for specific procedures, not carried out

117

1.97

2.40

6.2

4.5

—

Disorders of the thyroid gland

275

1473

1.21

2.40

3.8

3.9

—

Gingivitis and periodontal diseases

299

1281

1.21

2.40

4.2

3.9

—

Speech and linguistic disorders

2.29

2.39

5.5

5.7

—

Abnormalities of gait and mobility

281

1.61

2.39

3.9

4.2

—

Acute alcohol intoxication, ICD10

376

1.52

2.39

3.1

4.1

—

Nonalcoholic fatty liver disease

160

1.82

2.39

6.4

4.5

—

Toxic effect of other gases, fumes and vapours

6.36

2.38

2.6

8.9

—

Thrombotic microangiopathy

6.36

2.38

4.0

6.8

—

Contraceptive management

468

0.63

2.37

6.1

4.2

—

Other orthopaedic follow-up care

2.22

2.37

3.7

5.1

—

Malignant immunoproliferative diseases

4.18

2.37

4.1

6.4

—

Marginal zone B-cell lymphoma, including Hilmo

3.67

2.37

2.8

4.5

—

Alcohol abuse counselling and surveillance

3.67

2.37

3.0

4.4

—

Chronic tubulo-interstitial nephritis

2.43

2.37

2.8

3.8

—

Parapsoriasis

3.66

2.37

3.9

5.6

—

Hypertensive Heart Disease

445

1.42

2.36

3.9

4.0

—

Primary biliary cholangitis, wide definition

3.05

2.36

4.1

4.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.04

2.35

5.7

5.9

—

Noninfectious colitis NAS

251

1.64

2.35

4.0

3.9

—

Cyst of kidney

161

1.81

2.35

4.4

3.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

183

1.75

2.35

3.4

4.3

—

Mucosal proctocolitis

183

1.75

2.35

5.8

3.9

—

Mixed and other personality disorders

2.15

2.34

4.1

—

Malignant neoplasm of bladder, including Hilmo

295

1.58

2.32

3.1

4.1

—

Other congenital malformations

2.09

2.32

3.9

5.4

—

Achalasia of cardia

3.24

2.31

2.6

4.9

—

Other and unspecified urticaria

323

1.55

2.31

3.7

4.1

—

Persons encountering health services in circumstances related to reproduction

710

0.71

2.31

6.2

4.1

—

Psoriatic arthropathies

162

1.80

2.30

4.0

—

Other inflammation of eyelid, including avohilmo

108

807

1.34

2.29

3.8

4.0

—

Use of pramipexole

503

1.43

2.29

3.7

4.0

—

Other articular cartilage disorders

2.96

2.28

3.0

3.1

—

Cluster headache, strict

2.95

2.28

6.4

5.5

—

Alcohol abuse, main dg

269

1.60

2.28

2.9

4.2

—

Motor neuron disease (with DMD)

2.77

2.28

2.0

4.2

—

Other acute viral hepatitis

4.66

2.27

2.5

6.1

—

Vertical strabismus

2.57

2.27

3.4

4.7

—

Carcinoma in situ of skin

208

1.69

2.26

3.7

3.8

—

Use of disulfiram, acamprosate or naltrexone

134

1.87

2.26

2.5

3.9

—

Other bursopathies

278

1.59

2.24

3.1

4.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

674

1.37

2.23

3.6

4.1

—

Other and unspecified nail disorders

3.12

2.23

3.8

5.2

—

Other operation for atrial fibrillation

5.68

2.23

3.0

8.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

186

1.66

2.22

3.2

4.2

—

Nail disorders

135

1.86

2.22

3.8

4.8

—

Temporal arteritis

2.21

6.3

3.9

—

Systemic lupus erythematosus, unspecified

2.87

2.21

3.4

5.1

—

Peripheral arterial reconstruction

482

1.44

2.21

3.7

3.8

—

Dislocation, sprain and strain of joints and ligaments of head

2.69

2.20

3.2

6.2

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

121

1.91

2.20

2.5

4.8

—

Irritable bowel syndrome

482

1.43

2.20

3.8

4.0

—

Insomnia

238

1363

1.21

2.20

3.9

4.1

—

Foreign body on external eye

256

1.61

2.20

3.4

4.1

—

Olecranon bursitis

143

1.83

2.19

4.0

—

Iron deficiency

3.35

2.18

2.6

5.7

—

Disorders of optic nerve and visual pathways

136

1.84

2.17

9.3

4.7

—

Lichen sclerosus et atrophicus

203

1.68

2.17

6.5

4.2

—

Hypertension, Pulmonary Arterial

4.34

2.16

8.7

5.3

—

Gastrointestinal stromal tumor and sarcoma

3.73

2.16

3.7

4.4

—

Multiple myeloma and malignant plasma cell neoplasms

108

1.96

2.15

4.0

3.7

—

Aphakia

3.71

2.15

3.0

4.9

—

Senility

4.31

2.15

5.8

3.2

—

Other conjunctival vascular disorders and cysts

3.02

2.15

3.6

4.9

—

Systemic sclerosis

3.02

2.15

3.3

5.2

—

Seborrhoeic dermatitis

196

1.69

2.15

3.9

4.0

—

Spirochaetal infections, other/unspecified

180

0.39

2.15

3.0

4.3

—

Isolated proteinuria

2.63

2.14

2.4

4.3

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.17

2.14

2.9

6.2

—

Other disorders of Eustachian tube

2.63

2.14

6.3

4.4

—

Malignant neoplasm of prostate, including Hilmo

102

446

1.35

2.14

3.8

3.9

—

Biguanides

284

1437

1.19

2.14

3.6

3.9

—

Allergic purpura

2.79

2.14

6.1

5.2

—

Hidradenitis suppurativa

2.79

2.14

3.2

5.4

—

Carcinoma in situ of skin of trunk

2.11

2.13

3.4

3.6

—

Functional dyspepsia

536

1.40

2.12

4.9

3.8

—

Hyperplasia of prostate

133

577

1.30

2.12

4.6

3.5

—

Injuries to the knee and lower leg

341

1569

1.17

2.11

3.8

4.0

—

Retinal haemorrhage

2.47

2.11

3.7

4.1

—

Sleep disorders

246

1406

1.20

2.11

4.0

4.1

—

Other and unspecified erythematous conditions

2.46

2.10

4.2

—

Acute nasopharyngitis (common cold)

115

1.90

2.10

4.3

3.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

205

1.66

2.10

3.3

4.1

—

Diseases of spleen

3.22

2.10

2.1

4.2

—

Hypermetropia

102

1.96

2.09

3.6

5.1

—

Microscopic polyangiitis

5.09

2.08

9.2

7.9

—

Malignant neoplasm of bone and articular cartilage

5.05

2.07

2.4

6.1

—

Other and unspecified coagulation defects

2.27

2.07

5.0

4.5

—

Systemic sclerosis, icd10

2.92

2.07

3.3

5.2

—

Mumps

2.92

2.07

9.8

4.7

—

Dermatitis due to ingested food

4.11

2.06

9.0

4.9

—

Viral warts

146

1.79

2.06

5.3

4.6

—

Superficial injury of forearm

146

1.78

2.06

2.9

4.6

—

Other coagulation defects

117

1.89

2.06

4.2

4.1

—

Bullous disorders

110

1.92

2.05

3.9

3.8

—

Oesophagitis

103

1.95

2.05

3.8

3.7

—

malignant neoplasm of male genital organs

100

449

1.34

2.04

3.5

3.9

—

Fissure and fistula of anal and rectal regions

482

1.41

2.03

3.8

3.7

—

Benign neoplasm: Anus and anal canal

2.41

2.03

4.4

4.2

—

Attention to artificial openings

2.12

2.02

4.2

3.6

—

Ulcer of oesophagus

162

1.74

2.02

4.7

3.8

—

Other female pelvic inflammatory diseases

223

1.62

2.02

4.8

4.2

—

Ulcer of lower limb, not elsewhere classified

367

1.48

2.02

3.7

3.9

—

Systemic lupus erythematosus

2.51

2.01

3.7

4.7

—

Disorders resulting from impaired renal tubular function

2.23

2.01

4.9

3.9

—

Benign neoplasm: Skin of trunk

2.23

2.01

3.4

4.0

—

Drug-induced cataract

2.83

2.00

7.3

4.6

—

Family history of certain disabilities and chronic diseases leading to disablement

2.64

2.00

9.2

4.3

—

Mumps, including avohilmo

2.83

2.00

9.8

4.7

—

Pediculosis, acariasis and other infestations

2.01

2.00

4.1

5.2

—

Lichen simplex chronicus and prurigo

104

1.93

2.00

4.5

4.0

—

Diabetic retinopathy, excluding more controls

280

1.42

2.00

3.4

4.3

—

Elevated blood glucose level

155

1.75

2.00

4.2

3.9

—

Congenital malformations, deformations and chromosomal abnormalities

136

1015

1.27

2.00

4.2

4.1

—

Disorders of tooth development and eruption

181

1.62

1.98

4.1

4.0

—

Disorders of iron metabolism

3.36

1.97

3.4

3.0

—

Primary Sclerosing Cholangitis, IBD and UDCA required

3.35

1.97

3.3

5.5

—

Diseases of inner ear

168

1300

1.24

1.96

4.3

3.9

—

Chronic periodontitis, complicated

175

1386

1.23

1.96

3.6

4.0

—

Other and unspecified injuries of ankle and foot

2.36

1.95

7.4

5.1

—

Collapsed vertebra, not elsewhere classified

4.60

1.95

4.6

3.3

—

Congenital malformations of anterior segment of eye

4.60

1.95

5.4

7.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

179

1.68

1.95

3.9

3.7

—

Benign neoplasm of other and unspecified intrathoracic organs

4.59

1.94

3.2

7.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

4.57

1.94

3.0

7.6

—

SLE, ICD10

2.58

1.94

3.4

4.9

—

SLE, strict definition

2.58

1.94

3.4

4.9

—

Localized skin eruption due to drugs and medicaments

3.79

1.94

5.2

6.6

—

Abnormal findings on diagnostic imaging of breast

3.78

1.94

2.7

6.4

—

Assault by blunt object

3.78

1.94

2.0

7.0

—

Burn and corrosion of hip and lower limb, except ankle and foot

2.98

1.94

11.0

4.7

—

Alopecia areata

2.98

1.94

5.8

5.3

—

Systemic sclerosis (FG)

2.74

1.93

3.3

4.1

—

Manic episode

2.74

1.93

4.2

5.0

—

Colectomy operation

404

1.44

1.92

5.0

3.8

—

Reactive arthropathies

142

1.77

1.92

4.4

4.1

—

Other inflammation of eyelid

290

1.52

1.91

3.9

4.0

—

Salpingitis and oophoritis

266

1.54

1.91

4.0

4.4

—

Giant cell arteritis with polymyalgia rheumatica

2.06

1.91

6.2

3.8

—

Injuries to the ankle and foot

177

1232

1.23

1.91

3.9

4.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

145

897

1.26

1.90

3.7

4.0

—

Other or ill-defined heart diseases

2.01

1.90

2.8

4.1

—

Anti-inflammatory and antirheumatic products, non-steroids

339

1.35

1.90

3.6

4.0

—

Injury of muscle and tendon at wrist and hand level

235

1.58

1.89

3.9

4.2

—

Hypertrophy of breast

243

1.57

1.89

4.0

4.3

—

Spondylopathies in diseases classified elsewhere

3.21

1.88

2.7

3.2

—

Panhypopituitarism

3.20

1.88

2.9

4.7

—

Oligomenorrhoea

3.19

1.88

2.7

3.4

—

Bacterial, viral and other infectious agents

121

1.82

1.88

10.5

3.8

—

Alzheimer’s disease (Late onset), excluding more controls

267

0.58

1.88

3.0

3.9

—

Other erythematous conditions

2.32

1.88

4.2

—

Malignant neoplasm of head and neck, including Hilmo

212

1.61

1.87

3.5

4.8

—

Scabies, including avohilmo

181

1.66

1.87

3.6

4.3

—

Acquired haemolytic anaemia

2.66

1.87

3.7

4.6

—

Burns and corrosions of multiple and unspecified body regions

2.87

1.86

3.1

4.5

—

Hyperhidrosis

2.87

1.86

5.1

3.3

—

Malignant neoplasm of bladder

151

1.73

1.86

3.3

4.0

—

Postmenopausal atrophic vaginitis

245

1.43

1.85

3.9

4.3

—

Scleritis

3.56

1.84

3.3

5.9

—

Benign neoplasm: Endocrine pancreas

4.23

1.83

4.2

7.6

—

Chronic gastritis

655

1.33

1.83

4.3

3.8

—

Osteitis due to dental implant

4.22

1.83

3.2

6.8

—

Drug-induced polyneuropathy

4.21

1.83

2.4

7.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

4.20

1.83

3.4

5.6

—

Benign neoplasm: Bladder

4.20

1.82

2.2

7.6

—

4.18

1.82

8.2

5.2

—

Perforation of tympanic membrane

175

1.66

1.82

3.9

4.2

—

Dementia, including avohilmo

122

1052

0.79

1.82

3.4

3.9

—

Pustular psoriasis

2.13

1.82

2.7

4.2

—

Decubitus ulcer and pressure area

145

1.73

1.81

3.1

3.3

—

Ovarian cyst

278

1.40

1.81

5.3

4.2

—

Other demyelinating diseases of the central nervous system

2.58

1.80

2.8

4.5

—

Open wound of wrist and hand

119

905

1.27

1.79

3.8

—

Acute alcohol intoxication

554

1.36

1.79

3.0

4.2

—

Wet age-related macular degeneration

485

1.37

1.78

3.6

—

Other embolism and thrombosis

271

1.52

1.78

3.8

—

Other and unspecified follicular disorders

2.18

1.78

5.5

3.8

—

Disorders of orbit

2.18

1.78

3.9

4.7

—

Impetigo

2.35

1.77

3.7

6.8

—

Type 1 diabetes

428

1.40

1.76

5.7

3.8

—

Myeloproliferative diseases (CML excluded)

154

1.69

1.76

2.7

3.9

—

Cellulitis

471

1.38

1.76

4.1

—

Urolithiasis

106

826

1.29

1.75

3.8

3.9

—

Mesothelioma

3.37

1.75

1.5

4.7

—

Vascular diseases of the intestine

1.90

1.75

4.7

3.4

—

Helminthiases

3.35

1.75

2.5

6.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

120

909

1.26

1.74

4.2

4.0

—

Hypocalcemia

2.51

1.74

3.2

4.4

—

Collagenous colitis

170

1.65

1.73

3.5

4.2

—

Bacterial, viral and other infectious agents, including avohilmo

132

1.75

1.73

10.3

3.8

—

Primary biliary cholangitis (PBC)

2.68

1.72

4.1

4.5

—

Anomalies of pupillary function

2.93

1.72

4.7

5.6

—

Cerebral atherosclerosis

2.93

1.72

4.7

5.3

—

Other and unspecified pemphigoid

3.89

1.72

5.0

7.0

—

Disease of hard tissues of teeth, NOS

154

651

1.24

1.72

4.6

3.8

—

Inhalation and ingestion of food causing obstruction of respiratory tract

3.88

1.72

5.0

8.5

—

Malignant neoplasm of lip, including Hilmo

3.88

1.72

2.4

5.4

—

Arthropathy in ulcerative colitis

3.87

1.72

2.4

6.7

—

Infective bursitis

2.14

1.72

2.2

4.3

—

Toxic effect of other and unspecified substances

3.87

1.72

2.6

6.2

—

Malignant neoplasm of digestive organs, including Hilmo

128

749

1.26

1.71

3.8

4.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.14

1.71

4.4

4.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

253

1457

1.17

1.70

3.9

4.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

2.06

1.70

6.1

5.0

—

Duodenal ulcer

275

1.49

1.68

3.5

3.7

—

Mixed conductive and sensorineural hearing loss

259

1.51

1.67

5.8

3.8

—

Disorders of refraction and accommodation

465

1.37

1.67

4.4

3.9

—

Malignant neoplasm of prostate

441

1.30

1.67

3.5

3.9

—

Polyneuropathies and other disorders of the peripheral nervous system

553

1.34

1.67

4.6

3.9

—

Motor neuron disease ALS

2.52

1.67

2.1

4.3

—

Acidosis

2.52

1.67

2.4

3.4

—

Erythema nodosum

2.51

1.66

3.6

4.7

—

Malignant neoplasm of head and neck

172

1.63

1.66

3.4

4.7

—

Cluster headache, wide

2.51

1.66

6.4

5.4

—

Mesothelioma, including Hilmo

3.18

1.66

1.5

4.5

—

Mixed connective tissue disease

3.18

1.66

10.5

6.1

—

Fracture of skull and facial bones

400

1.40

1.66

2.9

4.1

—

Superficial injuries involving multiple body regions

2.59

1.66

3.6

4.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

362

1.42

1.65

3.1

4.1

—

Carcinoma in situ of skin of ear and external auricular canal

2.46

1.65

3.8

3.3

—

Right bundle-branch block

2.04

1.64

4.5

4.2

—

Other specified/unspecified soft tissue disorders

1.93

1.64

3.4

4.5

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.93

1.64

3.5

4.3

—

Chronic iridocyclitis

1.98

1.64

3.8

4.2

—

Other psoriatic arthropathies

165

1.64

4.2

4.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

401

1.40

1.64

3.5

3.9

—

Other aneurysm

127

1.74

1.64

3.2

3.4

—

Arterial embolism and thrombosis

127

1.74

1.63

5.8

3.4

—

Acute gastritis

150

1.67

1.63

3.2

3.9

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.61

1.62

4.6

5.1

—

Bullous keratopathy

3.61

1.62

4.6

6.5

—

Unspecified threat to breathing

3.60

1.62

6.4

6.1

—

Injury of nerves at shoulder and upper arm level

3.60

1.62

3.0

5.0

—

Disorders of porphyrin and bilirubin metabolism

3.60

1.62

4.8

2.9

—

Other contact dermatitis

120

1.75

1.62

3.3

3.9

—

Other shoulder lesions

158

1.65

1.62

3.5

4.6

—

Malignant neoplasm of tonsil

3.59

1.62

2.8

5.0

—

Other osteochondropathies

1.84

1.61

2.9

4.7

—

Pemphigoid

2.16

1.61

4.3

4.0

—

Disorders of synovium and tendon in diseases classified elsewhere

2.51

1.60

3.1

3.9

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.07

1.60

2.9

4.6

—

Other benign neoplasm of uterus: Other parts/unspecified

2.01

1.59

3.1

4.6

—

Arthropathic psoriasis

198

1.57

1.59

4.1

3.8

—

Monoamine oxidase A inhibitors

206

1.56

1.59

4.2

4.1

—

Burn and corrosion of trunk

2.34

1.59

2.6

5.5

—

Benign neoplasm of thyroid gland

2.34

1.59

4.1

4.5

—

Subacute thyroiditis

2.33

1.59

5.9

4.1

—

Disorders of psychological development

1.84

1.59

5.1

5.0

—

Other and unspecified injuries of wrist and hand

2.33

1.58

4.0

4.2

—

Malignant neoplasm of vulva, including Hilmo

3.02

1.58

4.3

5.4

—

Inflammatory diseases of prostate (prostatitis)

312

1.45

1.58

3.5

3.7

—

Hyperosmolality and hypernatraemia

3.02

1.58

2.5

3.5

—

Allergic contact dermatitis due to drugs in contact with skin

2.71

1.58

12.1

5.0

—

Myeloproliferative diseases

175

1.60

1.57

2.7

3.8

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

144

1.67

1.57

3.4

3.9

—

Otitis externa

456

1.36

1.56

3.5

3.8

—

Disorders of vestibular function (Vertigo)

142

1132

1.22

1.56

4.5

3.9

—

Chronic hepatitis, not elsewhere classified

2.28

1.55

7.5

4.5

—

Fracture of shoulder and upper arm

104

822

1.26

1.55

3.8

4.0

—

Recurrent aphthous stomatitis , including avohilmo

272

1.47

1.55

3.5

4.6

—

Other and unspecified glaucoma

160

1.63

1.55

3.7

3.9

—

Adenomyosis (Endometriosis of uterus)

191

1.57

1.55

4.4

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

148

1108

1.22

1.55

4.1

—

Migraine with aura and triptan purchases

168

1.61

1.54

4.8

4.4

—

Other and unspecified abdominal hernia

1.93

1.54

2.9

3.5

—

Crohn disease (strict definition, require KELA)

1.93

1.54

3.5

4.4

—

Congenital malformations of eye, ear, face and neck

1.98

1.53

3.8

5.8

—

Open wound of ankle and foot

192

1.57

1.53

3.3

4.2

—

Myalgia

415

1.38

1.53

3.4

4.3

—

Disorders of vitreous body

155

1220

1.21

1.53

3.8

4.0

—

Liposarcoma, including Hilmo

3.36

1.53

2.0

4.9

—

Hypertrophy of (infrapatellar) fat pad

3.36

1.53

4.4

4.6

—

Gout due to impairment of renal function

3.36

1.53

2.4

5.3

—

Diseases of tongue

100

1.80

1.52

3.1

3.7

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.35

1.52

3.4

6.3

—

Colorectal neuroendocrine tumor and carcinoma

3.35

1.52

4.6

5.1

—

Colitis, primary sclerosing

3.35

1.52

3.8

4.4

—

Antenatal screening

132

0.51

1.52

2.5

4.9

—

Other nutritional anaemias

3.36

1.52

4.8

4.2

—

Calculus of kidney and ureter

755

1.27

1.52

3.9

—

Haemorrhage in early pregnancy

346

1.40

1.52

3.4

4.3

—

Circumscribed brain atrophy

0.00

1.51

0.0

4.2

—

Restless leg syndrome

282

1.46

1.51

4.6

4.1

—

CR(E)ST syndrome

2.88

1.51

4.2

5.6

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

2.17

1.50

2.9

4.0

—

Burn and corrosion of head and neck

2.87

1.50

3.0

7.5

—

Tubulo-interstitial nephritis, not specified as acute or chronic

123

1.71

1.50

3.4

—

Cysts of oral region, not elsewhere classified

108

1.77

1.50

3.3

4.1

—

Presbyopia

108

1.76

1.50

6.0

4.3

—

Benign neoplasm: Other and unspecified parts of mouth

2.08

1.49

2.8

3.9

—

Special screening examination for infectious and parasitic diseases

207

0.56

1.49

4.9

4.2

—

Cluster headache, strict, including avohilmo

2.07

1.49

5.8

4.5

—

Migraine

566

1.28

1.49

4.4

4.2

—

Inflammatory disorders of breast

2.07

1.49

5.5

4.7

—

Thyroiditis, ILD-related definition

162

1.61

1.49

6.1

4.2

—

Bipolar affective disorders

234

1.50

1.48

3.3

4.1

—

Effects of foreign body entering through natural orifice

478

1.34

1.48

3.6

4.2

—

Post-traumatic wound infection, not elsewhere classified

2.44

1.48

3.2

4.3

—

Primary gonarthrosis, bilateral

171

1199

1.19

1.48

4.5

3.9

—

Other specified and unspecified personality disorders

109

1.75

1.46

2.8

4.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

343

1.40

1.46

3.0

4.1

—

Anankastic personality disorder

2.38

1.45

3.4

4.0

—

Redundant prepuce, phimosis and paraphimosis

421

1.36

1.45

3.5

3.8

—

Malignant neoplasm of tonsil and base of tongue

2.51

1.45

3.0

4.1

—

Other/unspecified synovitis and tenosynovitis

211

1.52

1.45

4.5

4.4

—

Disorders of vitreous body and globe

159

1255

1.20

1.45

3.8

4.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

637

1.29

1.44

4.0

—

Glucagon-like peptide-1 (GLP-1) analogues

637

1.29

1.44

4.0

—

Other ulcerative colitis

1.88

1.44

5.4

4.1

—

Other specified/unspecified inflammatory spondylopathies

2.12

1.44

2.9

4.9

—

Acquired stenosis of external ear canal

3.15

1.44

5.0

6.0

—

Injuries to the wrist and hand

280

1617

1.15

1.44

4.0

3.9

—

Fasciculation

3.15

1.44

2.4

6.0

—

Other disorders of central nervous system

3.15

1.44

3.8

6.8

—

Cramp and spasm

1.92

1.44

3.2

3.7

—

Diseases of external ear

101

806

1.25

1.43

4.1

3.8

—

Convalescence

1.92

1.43

3.9

3.7

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

2.74

1.43

3.2

4.4

—

Other secondary coxarthrosis

2.04

1.43

6.8

4.0

—

Perioral dermatitis

2.74

1.43

3.8

5.3

—

Crohn's disease of large intestine

1.98

1.43

2.5

4.6

—

Other secondary gonarthrosis

1.80

1.43

4.8

3.8

—

Psoriatic arthropathies, ICD10

172

1.57

1.42

4.2

—

Atrophic disorders of skin

278

1.44

1.41

6.5

4.0

—

Acetic acid derivatives and related substances

335

1.30

1.41

4.1

3.7

—

Degeneration of nervous system due to alcohol

2.26

1.40

2.3

4.8

—

Other vitreous opacities

1.86

1.40

3.0

3.6

—

Other congenital malformations of skin

2.18

1.40

3.6

6.5

—

Neuromuscular dysfunction of bladder

181

1.55

1.39

3.1

4.0

—

Acute posthaemorrhagic anaemia

1.90

1.39

4.7

3.9

—

Benign neoplasm of bone and articular cartilage

134

1.65

1.39

3.8

4.9

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.77

1.38

3.8

5.1

—

Stomatitis and related lesions

372

1.37

1.38

3.9

4.2

—

Other specified and unspecified retinal disorders

1.95

1.38

3.7

3.9

—

Sequelae of other and unspecified infectious and parasitic diseases

1.95

1.38

5.5

3.7

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

1.95

1.38

5.5

3.7

—

Inflammatory diseases of the central nervous system

142

1.62

1.38

2.5

4.2

—

Other specified/unspecified bacterial intestinal infections

119

1.69

1.37

3.9

3.6

—

Anosmia

3.00

1.37

2.8

5.4

—

Dementia

117

978

0.82

1.37

3.4

3.9

—

Abscess of Bartholin gland

2.62

1.37

5.2

4.2

—

Other menopausal disorders

238

1.36

3.4

4.3

—

Cholangitis (primary sclerosing, PSC)

127

1.66

1.36

3.3

3.9

—

Isolated proteinuria with specified morphological lesion

2.96

1.36

3.0

6.0

—

Horner syndrome

2.96

1.36

4.2

5.9

—

Other disorders of optic disc

2.96

1.36

12.0

6.4

—

Benign neoplasm: Other/unspecified site

2.96

1.36

3.6

5.5

—

Malignant neoplasm of oropharynx

2.96

1.36

2.8

5.0

—

Unspecified/other endometriosis

1.88

1.36

2.4

3.8

—

Fracture of foot, except ankle

425

1.34

1.36

4.3

4.0

—

Orchitis and epididymitis

223

1.48

1.35

3.1

3.9

—

Coxarthrosis, primary, with hip surgery

159

1241

1.19

1.35

3.7

4.0

—

Reactive arthropathies, FINNGEN

1.76

1.34

5.0

4.1

—

Trochanteric bursitis

273

1.43

1.34

5.9

4.1

—

Oesophageal varices

1.87

1.34

3.0

3.8

—

Diabetic nephropathy

395

1.35

1.34

3.3

4.0

—

Recurrent dislocation and subluxation of joint

1.87

1.34

3.3

3.9

—

Other and unspecified polyneuropathies, also in other diseases

487

1.32

1.33

4.9

3.9

—

Injury of muscle and tendon at shoulder and upper arm level

109

887

1.23

1.33

3.5

3.9

—

1.78

1.31

3.0

3.6

—

Certain zoonotic bacterial diseases

2.51

1.30

3.5

4.8

—

Carcinoma in situ of other and unspecified genital organs

2.51

1.30

7.3

5.4

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.10

1.30

3.4

3.9

—

Chronic Coagulation defects

2.51

1.30

3.3

5.0

—

Other and unspecified diseases of blood and blood-forming organs

2.10

1.30

3.0

3.7

—

Other and unspecified corneal deformities and disorders

2.10

1.30

4.9

4.2

—

Intrahepatic Cholestasis of Pregnancy (ICP)

2.10

1.30

6.9

4.0

—

Heart failure and hypertrophic cardiomyopathy

2.37

1.29

5.1

4.5

—

Hypertrophy of tongue papillae

2.79

1.28

2.6

6.0

—

Benign leiomyoma with endometriosis

259

1.43

1.28

5.2

4.2

—

UC patients in KELA-register (code 208), prior to 1994

1.89

1.28

4.8

4.2

—

Autoimmune hepatitis, wide definition

1.89

1.28

2.9

3.5

—

Acute lymphadenitis

1.89

1.28

2.6

5.5

—

Allergic conjunctivitis

123

978

1.21

1.28

4.2

4.0

—

Spontaneous rupture of synovium and tendon

169

1.54

1.28

3.4

4.6

—

Coxarthrosis, primary

200

1430

1.16

1.28

3.5

3.9

—

Amiodarone users

251

1.44

1.28

3.4

4.0

—

Carcinoma in situ of skin of upper limb, including shoulder

1.95

1.28

3.0

4.0

—

Pustulosis palmaris et plantaris

1.94

1.27

2.7

4.2

—

Cluster headache, wide,, including avohilmo

1.94

1.27

5.8

4.4

—

Radial styloid tenosynovitis [de Quervain]

1.94

1.27

3.6

5.4

—

Postprocedural disorders of nervous system

1.94

1.27

2.7

5.1

—

Anogenital herpesviral [herpes simplex] infection

2.00

1.27

3.2

4.5

—

Chronic diseases of tonsils and adenoids

156

828

1.19

1.27

3.9

3.7

—

Ulcerative proctitis

1.79

1.27

3.7

3.9

—

Symptoms and signs involving emotional state

2.29

1.27

6.5

5.6

—

Disorders of eyelid in diseases classified elsewhere

2.05

1.27

3.8

4.3

—

Maternal care for other conditions predominantly related to pregnancy

173

1.52

1.26

5.8

4.0

—

Secondary malignant neoplasm of respiratory and digestive organs

2.41

1.24

2.7

4.1

—

Other and unspecified acute skin changes due to ultraviolet radiation

2.23

1.24

3.6

4.0

—

Hypermobility syndrome

2.23

1.24

3.3

4.4

—

Degeneration of the brain due to alcohol

2.01

1.23

2.3

4.6

—

Other specified disorders of muscle

2.01

1.23

9.3

4.6

—

Helminthiases, including avohilmo

2.00

1.23

3.8

4.7

—

Sequelae of injuries, of poisoning and of other consequences of external causes

450

1.31

1.23

3.7

3.9

—

Coronary artery bypass grafting

495

1.26

1.23

3.4

3.6

—

Abscess of anal and rectal regions

139

1.59

1.23

2.6

4.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.05

1.22

3.8

4.4

—

Multiple myeloma

2.05

1.22

3.8

4.4

—

Traumatic subdural haemorrhage

316

1.36

1.22

3.8

4.0

—

Any dementia, excluding more controls

795

0.81

1.22

3.1

3.9

—

Pruritus

204

1.47

1.22

3.9

4.2

—

Other meningitis

2.64

1.21

3.0

6.9

—

Placenta praevia

2.64

1.21

2.8

4.4

—

Nonorganic sleeping disorders, excluding more controls

296

1.39

1.21

4.7

3.8

—

Calcific tendinitis of shoulder

1.73

1.21

5.5

5.1

—

Cervicocranial syndrome

188

1.49

1.21

4.1

4.0

—

Lateral epicondylitis

221

1.45

1.20

3.2

4.2

—

Chondropathies

246

1.42

1.20

3.1

4.5

—

Diaphragmatic hernia

106

871

1.22

1.20

4.0

3.8

—

Faecal incontinence

164

1.53

1.20

4.7

4.1

—

Meningitis

1.84

1.19

2.8

4.6

—

Portal vein thrombosis

2.32

1.19

2.8

3.8

—

Cardiomyopathy, Hypertrophic obstructive

2.32

1.19

5.8

3.6

—

Iridocyclitis in diseases classified elsewhere

2.32

1.19

3.2

5.1

—

Other congenital malformations of circulatory system

2.11

1.18

9.8

4.3

—

Other enthesopathy of foot (+metatarsalgia)

181

1.49

1.18

3.2

4.5

—

Memory loss

237

0.59

1.17

8.2

3.7

—

Other disorders of eye and adnexa

256

1.41

1.17

3.9

4.5

—

Hypertrophic cardiomyopathy

1.78

1.17

5.0

4.1

—

Systemic atrophies primarily affecting the central nervous system

1.78

1.17

2.4

3.9

—

Striking against or struck by other objects

630

1.25

1.17

3.5

3.9

—

Septal defects

1.82

1.17

3.4

5.7

—

Carcinoma in situ of cervix uteri

1.77

1.16

3.6

4.0

—

Failed induction of labour

0.00

1.16

0.0

3.4

—

Hypertrophy of breast in women and men

316

1.36

1.16

4.0

4.1

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

102

1.67

1.16

3.2

4.4

—

Normotensive glaucoma

215

1.45

1.15

4.0

3.8

—

Other bursitis of elbow

2.52

1.15

2.6

4.3

—

Autonomic disorders

2.06

1.15

3.6

4.7

—

Malignant neoplasm of tonsil, including Hilmo

2.51

1.15

2.8

4.4

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

2.51

1.15

14.4

4.7

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.51

1.15

3.2

5.3

—

Type 1 diabetes, wide definition, subgroup 1

316

1.36

1.15

6.4

3.8

—

Juvenile arthritis (FINNGEN)

2.06

1.15

2.0

6.6

—

Misadventures to patients during surgical and medical care

291

1.38

1.15

4.5

3.9

—

Malignant neoplasm of oesophagus, including Hilmo

1.85

1.13

3.2

4.1

—

Other acquired deformities of musculoskeletal system and connective tissue

1.85

1.13

4.3

4.8

—

Intestinal malabsorption

1.85

1.13

2.7

4.2

—

Migraine without aura

191

1.47

1.13

5.5

4.6

—

Statin medication

163

784

1.17

1.13

4.1

3.9

—

Diseases of male genital organs

150

640

1.18

1.13

4.1

3.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

573

1.26

1.12

3.8

4.0

—

Other extrapyramidal and movement disorders in other diseases

572

1.26

1.12

4.1

4.0

—

Operations for atrial fibrillation

2.35

1.12

3.0

4.3

—

Malignant neoplasm of oropharynx, including Hilmo

2.34

1.12

2.9

4.4

—

Ulcer of vagina/vulva

2.34

1.12

3.1

4.0

—

Anxiety (asthma-related co-morbidities)

124

790

1.19

1.12

4.8

4.2

—

Other bullous disorders

2.01

1.12

3.4

4.2

—

Corns and callosities

119

1.60

1.11

2.6

4.0

—

Somnolence, stupor and coma

1.71

1.11

2.6

3.9

—

Long labour

198

0.60

1.11

5.5

4.1

—

Other and unspecified disorders of vitreous body

124

1021

1.19

1.10

4.0

4.1

—

Ingrowing nail

1.79

1.10

4.3

5.1

—

Foreign body in alimentary tract

1.67

1.10

4.3

4.6

—

Myelodysplastic syndrome

2.39

1.09

3.4

4.6

—

Other and unspecified trigeminal disorders

2.39

1.09

4.4

4.0

—

Routine general health check-up of defined subpopulation

2.39

1.09

7.2

3.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

1.96

1.09

3.0

3.8

—

Congenital malformations of cardiac septa

1.78

1.09

3.4

5.7

—

Acne

1.77

1.09

2.8

5.7

—

Optic neuritis

1.96

1.09

10.4

4.4

—

Malignant neoplasm of digestive organs

112

714

1.20

1.08

3.8

4.1

—

Melanoma in situ of trunk

2.20

1.08

3.4

4.8

—

Astigmatism

1.73

1.08

3.4

5.2

—

Benign neoplasm: Choroid

128

1.57

1.08

8.5

4.0

—

Transport accidents

110

763

1.20

1.08

3.8

4.0

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

2.20

1.08

2.7

3.9

—

Cutaneous lupus erythematosus

2.20

1.08

4.0

3.8

—

Overexertion and strenuous or repetitive movements

163

0.55

1.08

3.7

3.9

—

Algoneurodystrophy

2.19

1.08

5.6

3.2

—

Gonarthrosis,primary

276

1482

1.12

1.08

4.1

3.8

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

157

912

1.17

1.08

4.5

4.2

—

Triptan medication for migraine, single purchase ok

157

912

1.17

1.08

4.5

4.2

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.69

1.07

3.6

5.1

—

Fracture of lower leg, including ankle

145

1219

1.17

1.07

3.6

4.1

—

Migraine with aura

295

1.36

1.07

4.5

4.2

—

Other diseases of spinal cord

1.93

1.06

4.2

4.1

—

Other disorders of the genitourinary system

253

1.39

1.06

5.7

4.0

—

Trigger finger

270

1.37

1.06

6.9

4.1

—

Continuous positive airway pressure

224

1.38

1.06

3.0

3.7

—

Malignant neoplasm of stomach

105

1.62

1.06

5.3

4.2

—

Malignant neoplasm of other connective and soft tissue

2.13

1.05

2.7

3.9

—

Other encephalitis

2.13

1.05

2.4

4.6

—

Glaucoma secondary to other eye disorders

1.71

1.05

3.4

3.7

—

Plantar fascial fibromatosis

179

0.56

1.04

4.0

4.4

—

Benign thyroid growths and nodules

654

1.22

1.04

4.6

4.1

—

Benign neoplasm: Short bones of upper limb

2.28

1.03

3.6

5.1

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.96

1.03

4.9

4.0

—

Inflammation of lacrimal passages (acute and unspecified)

2.28

1.03

5.0

6.0

—

Polyhydramnios

2.28

1.03

2.2

5.1

—

Renal cell carcinoma of kidney

1.84

1.03

3.5

3.8

—

Injury of muscle and tendon at hip and thigh level

179

1.46

1.02

3.7

4.0

—

Graves disease, strict definition

130

1.54

1.02

3.5

4.6

—

Benign neoplasm: other/unspecified salivary gland

1.92

1.02

4.2

4.3

—

Myeloid leukaemia

1.92

1.02

2.6

4.1

—

Malignant neoplasm of oesophagus

1.92

1.02

3.4

3.5

—

Bacterial meningitis

1.92

1.02

2.7

4.8

—

Retinal breaks without detachment

350

1.32

1.02

4.4

4.0

—

Cervicobrachial syndrome

394

1.30

1.01

4.1

4.2

—

Injuries involving multiple body regions

1.89

1.01

3.8

4.5

—

Congenital malformations of the circulatory system

215

1.40

1.01

5.0

4.5

—

Personal history of malignant neoplasm

106

0.47

1.01

2.2

4.5

—

Myocardial infarction, unclassifiable

583

1.23

1.00

4.1

3.7

—

All anxiety disorders

126

831

1.18

1.00

4.8

4.2

—

Other retinal artery occlusion

1.88

1.00

1.9

4.1

—

Idiopathic thrombocytopenic purpura

1.88

1.00

2.6

4.2

—

Other benign neoplasms of uterus

1.65

1.00

3.7

4.5

—

Post-traumatic stress disorder

1.77

1.00

4.0

5.8

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.88

1.00

6.9

4.1

—

Pure hypercholesterolaemia

211

1181

1.13

1.00

3.2

3.9

—

Injury of nerves and spinal cord at neck level

2.01

1.00

3.3

4.5

—

Benign neoplasm: Skin of lower limb, including hip

2.01

1.00

7.4

4.5

—

Barrett oesophagus

1.62

1.00

3.3

3.5

—

Macular hole

131

1.53

0.99

4.5

3.8

—

Malignant neoplasm of corpus uteri

131

1.53

0.99

2.8

4.9

—

Malignant neoplasm of stomach, including Hilmo

123

1.55

0.99

5.1

4.1

—

Benign neoplasm of eye and adnexa

231

1.39

0.99

6.5

4.3

—

Other specified/unspecified spondylopathies

1.84

0.98

2.7

3.5

—

Combinations of oral blood glucose lowering drugs

710

1.21

0.98

2.8

3.9

—

Malignant neoplasm of rectosigmoid junction

2.18

0.98

3.2

4.1

—

Crowding of teeth, including avohilmo

1.82

0.98

7.2

5.9

—

Idiopathic urticaria

2.18

0.98

2.8

5.7

—

Alzheimer disease, excluding more controls

306

0.74

0.98

3.6

3.8

—

Fall on same level involving ice and snow

153

1327

1.15

0.98

4.2

4.0

—

Intermittent heterotropia

1.80

0.98

3.9

5.7

—

Suicide or other Intentional self-harm

388

1.29

0.97

3.1

4.1

—

Paraplegia, diplegia of upper limbs

1.95

0.97

2.9

4.5

—

Encephalitis

1.95

0.97

2.4

4.6

—

Other acute skin changes due to ultraviolet radiation

1.81

0.96

7.1

3.9

—

Other specified/unspecified dorsopathies

1.80

0.96

2.4

4.2

—

Other disorders of optic [2nd] nerve and visual pathways

100

1.60

0.96

9.2

4.6

—

Other diseases of peritoneum

1.74

0.96

3.8

4.1

—

Generalized anxiety disorder

173

1.44

0.96

2.7

4.5

—

Hydronephrosis

241

1.37

0.96

3.9

4.1

—

Fracture of forearm

139

1077

1.16

0.95

4.7

4.1

—

Injury of nerves at wrist and hand level

1.77

0.94

2.0

4.5

—

Neovascular glaucoma

1.65

0.94

3.4

3.7

—

Other symptoms and signs involving general sensations and perceptions

1.65

0.94

6.2

4.2

—

Pericarditis

1.78

0.94

3.9

3.6

—

Malignant neoplasm of tongue, including Hilmo

1.90

0.94

2.7

3.9

—

Dislocation, sprain and strain of joints and ligaments at neck level

208

1.40

0.94

5.7

4.4

—

Pedestrian injured in collision with car, pick-up truck or van

2.23

0.93

6.7

5.1

—

Tongue abnormality

109

1.56

0.93

3.1

4.6

—

Retinal vascular disorders

303

1.32

0.93

3.8

3.7

—

Carcinoma in situ of breast, intraductal

145

0.55

0.92

3.9

4.6

—

Other predominantly sexually transmitted diseases, not elsewhere classified

175

1.43

0.92

4.2

4.3

—

Postprocedural disorders of digestive system, not elsewhere classified

1.74

0.92

5.6

3.7

—

Myelodysplastic syndrome, including Hilmo

1.82

0.92

3.4

4.0

—

Benign neoplasm: Larynx

1.82

0.92

3.4

3.8

—

Type 1 diabetes, strict definition, subgroup 1

1.73

0.92

3.6

3.4

—

Periapical abscess

117

1001

1.17

0.92

3.9

4.1

—

Perichondritis of external ear

2.15

0.91

4.8

5.3

—

Hyperprolactinaemia

2.15

0.91

3.3

4.4

—

Crohn disease (strict definition, require KELA, min 2 HDR)

1.67

0.91

3.7

4.4

—

Cervicalgia

401

1.27

0.91

3.5

4.1

—

Infections with a predominantly sexual mode of transmission

400

1.27

0.91

3.5

3.9

—

Enthesopathies of lower limb, excluding foot

410

1.27

0.91

3.8

4.5

—

Malignant melanoma

322

1.31

0.91

3.1

4.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.63

0.90

6.1

4.8

—

Infectious mononucleosis, including avohilmo

1.75

0.90

2.7

5.2

—

Infectious mononucleosis

1.75

0.90

2.7

5.2

—

Supervision of normal pregnancy

126

0.63

0.89

2.5

4.7

—

Other obstructed labour

1.69

0.88

5.2

4.6

—

Bursitis of shoulder

1.91

0.88

6.0

3.8

—

Obstructed labour due to malposition and malpresentation of fetus

179

1.40

0.88

5.7

4.0

—

Other/unspecified disorders of vestibular function

1.65

0.88

4.0

3.9

—

Dronedarone medication

1.79

0.88

3.6

4.1

—

Arterial embolism and thrombosis of lower extremity artery

1.65

0.88

3.5

3.3

—

Amyloidosis

1.87

0.87

7.7

3.2

—

Other benign neoplasms of skin

104

886

1.17

0.87

3.6

3.9

—

Pediculosis, acariasis and other infestations, including avohilmo

237

1.35

0.87

3.6

4.4

—

Retinal vascular occlusion

298

1.31

0.87

3.7

3.8

—

Pulmonary oedema

2.01

0.87

4.2

4.9

—

Urethritis and urethral syndrome

2.01

0.87

2.2

3.5

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

168

0.59

0.87

2.3

3.8

—

Polycystic ovarian syndrome

2.00

0.87

4.7

3.9

—

Endometriosis

274

1.25

0.87

4.0

4.2

—

Hereditary corneal dystrophies

1.72

0.86

5.7

4.6

—

Testicular dysfunction

1.72

0.86

4.5

4.3

—

Other and unspecified mononeuropathies of lower limb

1.82

0.86

3.4

3.8

—

Disorders of breast

723

1.18

0.86

4.3

4.2

—

Other surgical follow-up care

1.82

0.86

2.4

4.2

—

Other diseases of stomach and duodenum

128

1.49

0.85

4.1

—

Artificial joint re-operation

145

1.45

0.84

3.8

4.1

—

Type 1 diabetes, wide definition

352

1.28

0.84

6.4

3.8

—

Sequelae of injuries of lower limb

145

1.45

0.84

2.9

4.0

—

Carcinoma in situ of other and unspecified sites

104

1.54

0.84

3.0

3.5

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.94

0.84

3.7

4.6

—

Benign neoplasm of male genital organs

1.79

0.84

2.7

2.9

—

Poor fetal growth

1.63

0.84

3.7

3.5

—

Open wound of abdomen, lower back and pelvis

1.78

0.84

4.1

5.0

—

Trigeminal neuralgia

1.57

0.84

3.9

3.7

—

Other disorders of eyelid

138

1137

1.15

0.84

3.3

3.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

496

1.23

0.84

3.9

4.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

137

1.46

0.84

4.4

4.5

—

Bicuspidal aortic valve syndrome

1.76

0.83

2.7

5.1

—

Retinal detachments and breaks

107

918

1.17

0.83

3.9

3.8

—

Extrapyramidal and movement disorders

114

984

1.16

0.82

3.7

4.0

—

Chronic mastoiditis

1.75

0.82

3.3

4.3

—

Adenocarcinoma and papillary adenocarcinoma of stomach

1.74

0.82

5.0

3.8

—

Normal-pressure hydrocephalus

115

0.52

0.82

3.0

3.7

—

Hallux rigidus

273

0.70

0.82

3.7

4.1

—

L02BB Anti-androgens

296

0.71

0.82

3.1

3.6

—

Synovial cyst of popliteal space [Baker]

146

1.44

0.82

3.7

4.7

—

Excessive vomiting in pregnancy

1.69

0.82

5.1

4.8

—

Disorders of optic nerve, not elsewhere classified

1.88

0.82

7.0

4.6

—

Other juvenile arthritis

1.88

0.82

1.8

5.6

—

Burns and corrosions

223

1.35

0.81

5.3

4.2

—

Other superficial mycoses, including avohilmo

138

1.45

0.81

4.0

4.2

—

225

0.67

0.81

2.7

3.7

—

Endometriosis of rectovaginal septum and vagina

1.61

0.81

3.9

4.2

—

Bullous pemphigoid

1.71

0.81

3.4

4.3

—

All dysplastic lesions of the vulva

1.71

0.80

4.9

—

Other mental disorders due to brain damage and dysfunction and to physical disease

311

1.29

0.80

3.3

3.8

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

147

1.43

0.80

3.0

3.9

—

Other fall from one level to another

436

1.24

0.80

3.8

4.2

—

Carcinoma in situ of colon

1.73

0.79

6.2

3.8

—

Monoarthritis, not elsewhere classified

1.73

0.79

2.7

3.2

—

Other and unspecified mood [affective] disorders

1.73

0.79

3.3

6.7

—

1.73

0.79

2.8

3.3

—

Other inflammatory liver diseases

114

1.49

0.79

3.1

4.2

—

Viral infections of the central nervous system, including avohilmo

114

1.49

0.79

2.9

4.4

—

Alzheimer’s disease (undefined)

0.00

0.79

0.0

4.7

—

Burns and corrosions confined to eye and internal organs

1.82

0.79

3.5

5.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

207

1.35

0.79

4.0

4.4

—

Small cell lung cancer, including Hilmo

1.67

0.79

2.0

3.7

—

Small cell lung cancer

1.67

0.79

2.0

3.7

—

Other noninflammatory disorders of vulva and perineum

106

1.51

0.78

3.6

4.1

—

Vestibular neuronitis

173

1.39

0.78

4.0

4.2

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

407

0.76

0.78

5.5

4.2

—

Acne vulgaris

1.66

0.78

3.4

6.5

—

Other disorders of nervous system

131

1.45

0.78

3.9

4.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1.56

0.78

3.3

4.1

—

Hemiplegia

1.59

0.78

2.8

4.0

—

Other infestations, including avohilmo

0.00

0.77

0.0

4.7

—

Hypoglycaemia, other or unspecified

123

1.47

0.77

3.9

4.0

—

Speech disturbances, not elsewhere classified

208

1.35

0.77

3.6

4.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

454

1.19

0.77

4.9

4.3

—

Specific development disorders of scholastic skills

0.00

0.77

0.0

7.3

—

Malignant neoplasm of breast, including Hilmo

454

1.19

0.77

4.9

4.3

—

Exposure to other and unspecified animate mechanical forces

1.77

0.76

3.7

5.5

—

Sudden idiopathic hearing loss

200

1.35

0.76

3.6

3.8

—

Car occupant injured in other and unspecified transport accidents

314

1.28

0.76

3.6

4.3

—

Status epilepticus

1.70

0.76

2.8

4.6

—

Benign neoplasm: Conjunctiva

1.70

0.75

3.3

4.1

—

Muscle strain

1.70

0.75

7.7

4.6

—

Hydrocephalus

173

0.63

0.75

2.9

3.9

—

Other and unspecified visual disturbances

192

1.36

0.75

3.3

4.3

—

Chronic myeloproliferative disease

2.09

0.74

2.6

5.2

—

Other and unspecified hydrocephalus

2.09

0.74

2.2

5.0

—

Injury of urinary and pelvic organs

2.09

0.74

3.6

5.0

—

Viral conjunctivitis

2.09

0.74

4.6

5.4

—

Malignant neoplasm of breast

453

1.18

0.74

4.9

4.3

—

Childhood allergy (age < 16)

1.65

0.74

10.8

3.6

—

Unspecified dementia

301

0.74

2.8

3.6

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.85

0.73

3.0

3.8

—

Other and specified injuries of hip and thigh

1.85

0.73

3.6

5.1

—

Degenerative macular diseases

289

1.28

0.73

5.2

3.9

—

Loose body in joint

1.85

0.73

5.4

3.3

—

Seborrhoeic keratosis

615

1.19

0.73

3.8

—

Lesion of sciatic nerve

100

1.50

0.73

4.7

3.5

—

Erosion and ectropion of cervix uteri

2.00

0.72

2.8

5.2

—

Malignant melanoma, including Hilmo

370

1.24

0.72

3.2

4.3

—

Dentofacial anomalies [including malocclusion]

149

1035

1.13

0.72

4.7

3.9

—

Type 1 diabetes, strict definition

1.60

0.72

3.6

3.5

—

Retained placenta and membranes, without haemorrhage

159

0.63

0.72

2.3

4.4

—

Temporomandibular joint disorders, including avohilmo

686

1.17

0.71

4.5

4.1

—

Intestinal adhesions without obstruction

185

1.35

0.71

4.0

—

Testicular hypofunction

1.58

0.71

4.8

3.9

—

Colonic or urogenital fistula

599

1.19

0.71

3.7

3.9

—

Vertigo of central origin

1.93

0.70

2.8

5.5

—

Laparoscopic left hemicolectomy

1.93

0.70

3.8

4.8

—

Burn and corrosion confined to eye and adnexa

1.93

0.70

3.6

4.8

—

Abnormal serum enzyme levels

839

0.85

0.70

4.9

3.8

—

Injuries to the neck

417

1.22

0.70

4.9

4.1

—

Benign neoplasm: Rectum, anus and anal canal

518

1.20

0.69

3.6

3.9

—

Dementia in Alzheimer disease

509

0.82

0.69

3.1

3.6

—

Hyperkinetic disorders, excluding more controls

1.60

0.69

12.7

4.1

—

Unspecified privation

204

1.33

0.68

3.8

4.0

—

Malignant neoplasm of tongue

1.86

0.68

2.6

3.9

—

Benign neoplasm: Skin of upper limb, including shoulder

1.86

0.68

2.8

5.1

—

Injury of intra-abdominal organs

1.86

0.68

3.2

4.4

—

Unspecified lump in breast

248

1.29

0.68

4.5

4.0

—

Undefined dementia

305

0.76

0.68

2.8

3.7

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.67

0.68

5.4

4.6

—

Inguinal or femoral hernia, bilateral

275

1.27

0.68

4.1

3.6

—

Right hemicolectomy

127

1.42

0.68

4.2

3.6

—

Dementia in other diseases classified elsewhere

119

0.59

0.67

4.3

3.5

—

Malignant neoplasm of breast, HER2-negative

452

1.17

0.67

5.0

4.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

383

1.23

0.67

3.3

4.0

—

Triptan medication for migraine, min. 3 purchases

629

1.15

0.67

5.1

4.1

—

Ascites

153

1.37

0.67

2.7

4.3

—

Diseases of appendix

182

1471

1.11

0.66

4.2

4.0

—

Use of galantamine

226

0.71

0.66

3.9

3.7

—

Nontoxic goitre/thyroid nodule

613

1.18

0.66

4.9

3.9

—

Contusion of toe(s) without damage to nail

1.79

0.66

2.4

5.0

—

Covid-19 suspected case

330

1.24

0.66

3.7

4.1

—

Pregnancy examination and test

0.60

0.66

2.5

4.8

—

Macular pucker

412

1.22

0.65

5.6

3.7

—

Metatarsalgia

171

1.35

0.65

2.9

4.6

—

Subarachnoid haemorrhage

225

0.71

0.65

2.8

4.3

—

Sequelae of injuries of neck and trunk

1.59

0.65

5.7

3.9

—

Atopic conjunctivitis

1.59

0.65

5.0

4.8

—

Multiple gestation

1.57

0.65

4.9

4.5

—

Diseases of the myoneural junction and muscle

277

1.27

0.65

3.2

4.1

—

Propionic acid derivatives

339

1.17

0.64

3.5

4.0

—

Carcinoma in situ, bladder

1.48

0.64

3.1

3.3

—

Excessive attrition of teeth

136

1202

1.12

0.64

4.0

—

Corneal degeneration

1.73

0.64

2.8

4.8

—

Pyoderma

1.73

0.64

6.8

4.9

—

Erythema multiforme

1.73

0.64

3.6

5.1

—

Exposure to smoke, fire and flames

1.73

0.64

3.0

4.4

—

Other congenital malformations of face and neck

1.73

0.64

2.2

5.6

—

Paralytic ileus

1.50

0.63

2.8

4.0

—

Benign neoplasm of colon, rectum, anus and anal canal

197

1517

1.10

0.63

4.0

3.9

—

Thyrotoxicosis with diffuse goitre

216

1.30

0.63

3.2

4.2

—

Impotence

138

1.38

0.62

3.1

3.6

—

LSIL lesion of the cervix uteri

104

1.44

0.62

4.2

—

Superficial injury of ankle and foot

164

1.34

0.62

3.7

4.5

—

Herpesviral keratitis and keratoconjunctivitis

1.55

0.62

3.7

3.8

—

Small fibre neuropathy

1.64

0.62

2.5

4.1

—

Cerebral palsy and other paralytic syndromes

199

1.31

0.62

3.0

4.6

—

Atopic dermatitis

116

818

1.13

0.62

4.6

3.9

—

Carpal tunnel syndrome

157

1227

1.11

0.62

3.7

4.0

—

Paralytic strabismus

147

1.36

0.61

2.6

3.6

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

1.67

0.61

3.2

4.3

—

malignant neoplasm of female genital organs, including Hilmo

283

1.25

0.61

3.4

4.3

—

Congenital ovarian cysts

1.67

0.61

5.6

4.0

—

Melanoma in situ

1.46

0.61

3.1

4.0

—

Demyelinating diseases of the central nervous system

1.46

0.61

2.7

4.6

—

Medical abortion

120

575

1.13

0.61

3.9

4.3

—

Other deformities of toe(s)

1.60

0.61

7.2

5.1

—

Arthropathies in other diseases classified elsewhere

1.60

0.61

6.6

3.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

1.60

0.61

3.1

4.5

—

Ovarian dysfunction

1.60

0.61

4.2

4.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

434

1.20

0.61

3.1

4.0

—

Carcinoma in situ of other and unspecified digestive organs

1.48

0.60

5.4

3.7

—

Early lumbar disc prolapse, operated

1.48

0.60

5.3

3.8

—

Other peripheral vertigo

200

1.30

0.60

5.8

4.4

—

Spinal enthesopathy

1.57

0.60

2.0

3.5

—

Female genital prolapse

260

1.20

0.60

5.1

4.2

—

Other complications of labour and delivery, not elsewhere classified

1.58

0.60

2.9

3.2

—

Other congenital malformations of the digestive system

1.56

0.60

3.5

6.2

—

Benign lipomatous neoplasm

657

1.16

0.60

3.7

3.8

—

Visual field defects

174

1.32

0.60

9.7

4.0

—

Examination and observation for other reasons

135

681

1.12

0.59

4.3

3.6

—

Other disorders of iris and ciliary body

1.54

0.59

3.8

4.1

—

Other and unspecified intracranial injuries

1.54

0.59

6.5

4.6

—

Fall on and from stairs and steps

565

1.17

0.59

4.2

4.0

—

Other arterial embolism and thrombosis

1.57

0.58

8.5

3.4

—

Maternal care for known or suspected fetal abnormality and damage

0.62

0.58

4.6

3.2

—

Congenital malformations of aortic and mitral valves

1.57

0.58

2.7

6.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

475

1.17

0.57

3.4

4.2

—

Cyst of Bartholin Gland

1.72

0.57

4.2

4.1

—

Ectropion of eyelid

106

1.42

0.57

2.7

3.7

—

Malignant neoplasm of corpus uteri, including Hilmo

149

1.34

0.57

2.8

4.7

—

Lichen simplex chronicus

1.48

0.57

3.9

—

Spermatocele

202

1.29

0.57

3.5

3.7

—

Other obstetric conditions, not elsewhere classified

143

1.28

0.57

4.9

3.7

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

525

0.85

0.57

3.7

4.3

—

Other crystal arthropathies

1.67

0.56

1.8

3.3

—

Syphilis, including avohilmo

1.67

0.56

2.2

4.1

—

Syphilis

1.67

0.56

2.2

4.1

—

Contact with machinery

238

1.26

0.56

2.6

3.6

—

Prepatellar bursitis

1.43

0.56

2.9

4.0

—

Calculus of lower urinary tract

141

1.35

0.56

2.7

3.7

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.51

0.56

4.0

3.6

—

Motorcycle rider injured in other and unspecified transport accidents

1.51

0.56

3.6

5.9

—

MS-disease / Multiple Sclerosis

1.51

0.56

2.7

4.4

—

Malignant neoplasm of breast, ER-positive, including Hilmo

428

1.16

0.56

3.9

4.3

—

Gluteal tendinitis

1.46

0.56

4.9

4.1

—

Appendicitis, broad definition

179

1468

1.09

0.56

4.2

4.0

—

Amyloidosis, other/unspecified

1.63

0.55

2.8

3.2

—

Fourth [trochlear] nerve palsy

1.63

0.55

2.5

4.5

—

Panic disorder

150

1.33

0.55

5.5

4.7

—

Twin gestation

1.54

0.55

4.6

3.9

—

Biomechanical lesions, not elsewhere classified

1.45

0.55

2.8

3.9

—

Unspecified jaundice

107

1.40

0.55

2.9

4.6

—

Inguinal hernia, bilateral

275

1.24

0.55

3.9

3.6

—

Other misadventures during surgical and medical care

1.58

0.54

3.7

4.4

—

Benign neoplasm: Rectosigmoid junction

1.47

0.54

3.7

3.8

—

Pedestrian injured in collision with pedal cycle

1.58

0.54

6.0

5.3

—

Atrial septal defect

1.57

0.54

2.7

7.1

—

Other neurotic disorders

1.49

0.53

3.2

4.4

—

Atypical facial pain

1.49

0.53

4.1

4.6

—

Crystal arthropathies, rheuma endpoint

1.54

0.53

1.8

3.7

—

Complications of labour and delivery

107

529

1.12

0.53

4.0

4.2

—

Viral infections of the central nervous system

108

1.39

0.53

2.9

4.1

—

Hepatic failure, not elsewhere classified

1.52

0.52

2.4

4.2

—

Superficial injury of shoulder and upper arm

232

1.25

0.52

3.5

4.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

713

1.14

0.52

3.9

—

Foreign body or object entering through skin

100

1.40

0.51

2.9

5.1

—

Melanocytic naevi of other and unspecified parts of face

1.45

0.51

2.7

4.5

—

Acute appendicitis, no complications

121

1085

1.11

0.51

4.6

4.0

—

Oral lichen planus

1.50

0.51

2.3

4.9

—

Ulcerative enterocolitis

1.50

0.51

5.8

4.2

—

Pregnancy with abortive outcome

124

581

1.11

0.51

3.5

4.3

—

Other congenital malformations, including avohilmo

161

1.30

0.51

4.0

4.8

—

Benign neoplasm: Sigmoid colon

489

0.84

0.51

3.3

3.9

—

Polyp of the female genital tract

265

1.18

0.51

4.3

4.2

—

Malignant neoplasm of breast, HER-positive

426

1.15

0.51

3.9

4.3

—

Other and unspecified myopathies

206

1.26

0.50

2.9

3.9

—

Dissection of aorta

1.47

0.50

2.6

3.4

—

Fall involving bed

1.47

0.50

3.0

4.1

—

Dislocation, sprain and strain of joint and ligaments of hip

1.47

0.50

3.3

4.0

—

Sixth [abducent] nerve palsy

1.39

0.50

3.0

3.8

—

Contusion of other and unspecified parts of foot

1.39

0.50

3.9

5.5

—

L02BX Other hormone antagonists and related agents

168

0.71

0.50

2.6

3.3

—

Crossbite

1.38

0.50

10.9

4.0

—

Erythema intertrigo

1.47

0.50

2.7

4.2

—

Certain zoonotic bacterial diseases, including avohilmo

1.47

0.50

3.5

4.4

—

Anisometropia and aniseikonia

1.47

0.50

4.7

4.4

—

Other disorders of glucose regulation and pancreatic internal secretion

153

1.31

0.50

3.7

4.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

324

1.15

0.50

3.9

3.7

—

Benign neoplasm: Caecum

269

0.78

0.50

3.4

4.1

—

Prolonged pregnancy

1.38

0.50

3.3

3.9

—

Benign paroxysmal vertigo

697

1.13

0.50

4.7

3.9

—

L02BA Anti-estrogens

280

0.78

0.49

4.0

4.1

—

Sequelae of injuries of head

1.43

0.49

3.7

4.3

—

Benign neoplasm: Stomach

201

0.75

0.49

3.1

4.3

—

Generalized epilepsy

1.56

0.49

3.0

5.9

—

Focal epilepsy, strict definition

432

0.83

0.48

5.1

4.1

—

Postpartum hemorraghe, all women as controls

211

1.25

0.48

4.9

4.1

—

Dermatophytosis, including avohilmo

162

1459

1.09

0.48

4.0

3.9

—

Dystonia

1.45

0.48

3.4

4.4

—

Embedded teeth, including avohilmo

1.45

0.48

4.5

5.7

—

Congenital malformations and deformations of the musculoskeletal system

1.42

0.48

4.4

5.5

—

Nontraumatic intracranial haemmorrhage

528

0.85

0.47

2.9

4.0

—

Viral conjunctivitis, including avohilmo

1.49

0.47

4.7

5.8

—

Supervision of high-risk pregnancy

121

0.74

0.47

3.7

5.0

—

Acute appendicitis

163

1392

1.09

0.47

4.3

4.0

—

Colorectal cancer, including Hilmo

600

1.13

0.47

3.6

4.1

—

Central retinal artery occlusion

1.46

0.47

3.9

4.2

—

Erectile dysfunction

218

1.24

0.46

3.7

3.2

—

Injury of eye and orbit

227

1.23

0.46

3.5

4.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

227

1.23

0.46

4.2

—

Primary hyperparathyroidism

218

1.24

0.46

3.3

4.2

—

Secondary parkinsonism, excluding more controls

1.43

0.46

3.1

3.9

—

Panniculitis affecting regions of neck and back

1.43

0.46

3.7

3.4

—

Fracture at wrist and hand level

681

1.13

0.45

5.5

3.9

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

118

0.68

0.45

4.4

4.6

—

malignant neoplasm of female genital organs

258

1.21

0.45

3.4

4.2

—

Secondary parkinsonism+Parkinsonism in other disease

1.40

0.45

3.1

4.2

—

Benign neoplasm of other and unspecified sites

1.40

0.45

4.3

4.2

—

Malignant neoplasm of oral cavity

1.40

0.45

3.0

3.8

—

Other puerperal infections

1.40

0.45

4.0

4.3

—

Noninflammatory disorders of female genital tract

280

1.15

0.45

5.1

4.1

—

Nontoxic multinodular goitre

394

1.17

0.44

5.4

4.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

137

1.24

0.44

5.1

3.7

—

Malignant neoplasm of oral cavity, including Hilmo

1.45

0.44

3.0

4.3

—

Nonorganic sleeping disorders

348

1.18

0.44

4.7

4.2

—

Colon adenocarcinoma, helper endpoint

351

0.83

0.44

3.8

3.9

—

Early lumbar disc prolapse operation

1.37

0.43

5.3

3.9

—

Diabetic retinopathy

542

1.11

0.43

3.3

4.0

—

Special screening examination for neoplasms

129

0.70

0.43

4.3

3.9

—

Other and unspecified local infections of skin and subcutaneous tissue

184

1.25

0.43

5.6

4.1

—

Glaucoma-related operations

130

0.69

0.43

4.6

4.0

—

Disturbance of activity and attention

1.41

0.43

12.7

4.1

—

Oesophageal obstruction

1.41

0.43

4.1

3.9

—

Third [oculomotor] nerve palsy

1.62

0.43

2.0

4.9

—

Myocardial infarction, with ST-elevation

489

1.15

0.43

3.6

3.8

—

Toxic effect of alcohol

1.62

0.43

2.0

5.5

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.62

0.43

5.0

5.2

—

Other renal tubulo-interstitial diseases

1.62

0.43

4.6

4.8

—

Effects of other external causes

1.62

0.43

5.4

4.6

—

Maternal care for known or suspected abnormality of pelvic organs

154

1.23

0.43

5.3

4.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

129

1.28

0.42

12.8

3.9

—

Small cell lung cancer, helper endpoint

1.41

0.42

2.0

3.9

—

Persistent delusional disorders

131

1.30

0.42

3.1

4.2

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

185

1.21

0.42

3.8

3.7

—

Graves ophthalmopathy

1.52

0.41

5.0

4.8

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

1.52

0.41

5.2

4.5

—

Crystalline deposits in vitreous body

0.00

0.41

0.0

6.1

—

Severe visual impairment, monocular

0.00

0.41

0.0

6.5

—

Other abnormal products of conception

208

0.82

0.41

4.8

4.4

—

Peptic ulcer

0.00

0.41

0.0

5.9

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.41

0.0

6.5

—

Anxious personality disorder

0.00

0.41

0.0

4.6

—

Benign neoplasm of ovary

286

1.19

0.41

4.1

4.3

—

Sequelae of poliomyelitis, including avohilmo

0.00

0.41

0.0

6.0

—

Leiomyoma of uterus

123

631

1.09

0.40

4.1

4.2

—

Open wound of thorax

0.00

0.40

0.0

5.6

—

Malignant neoplasm of cervix uteri

0.00

0.40

0.0

5.0

—

Congenital malformations of uterus and cervix

0.00

0.40

0.0

5.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

259

1.20

0.40

2.7

4.1

—

Vascular dementia (multiple infarctions)

1.47

0.40

2.6

4.8

—

Convergent concomitant strabismus

1.33

0.40

4.4

5.7

—

Parkinson's disease, strict definition

390

0.85

0.40

2.8

4.0

—

Other problems related to primary support group, including family circumstances

1.35

0.40

4.1

5.7

—

Malignant neoplasm of urinary organs, including Hilmo

241

1.20

0.40

3.0

4.7

—

Glucosamine medication

122

1059

0.92

0.40

3.5

3.9

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.39

0.0

5.0

—

Rheumatic valve diseases

1.43

0.39

2.8

4.8

—

Sleep disorders, other/unspecified

1.43

0.39

3.0

5.0

—

Lagophthalmos

0.00

0.39

0.0

5.9

—

Chalazion

204

0.78

0.39

3.4

4.1

—

Diabetic retinopathy, strict definition

326

0.84

0.38

3.0

4.1

—

Premature rupture of membranes

126

1.24

0.38

4.1

4.2

—

Other congenital malformations of the digestive system, including avohilmo

1.38

0.38

3.4

5.4

—

Single delivery by forceps and vacuum extractor

0.69

0.38

3.8

—

Inflammatory disease of uterus

160

1.25

0.38

3.3

4.1

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.37

0.38

4.0

4.4

—

Crohn disease (strict definition, all UC cases excluded)

1.37

0.38

4.3

4.6

—

Other specific arthropathies, wide

1.39

0.38

2.6

3.9

—

Other and unspecified disease of Bartholin gland

1.39

0.38

2.8

5.0

—

Hallux valgus (acquired)

488

1.11

0.38

5.2

4.1

—

Postpartum hemorraghe, parous women as controls

187

1.21

0.38

4.9

4.5

—

Perineal laceration during delivery

0.70

0.37

6.2

4.0

—

Hyphaema and other vascular disorders of iris and ciliary body

1.35

0.37

4.4

4.6

—

Congenital iodine-deficiency syndrome/hypothyroidism

1.35

0.37

3.0

4.7

—

Nonspecific lymphadenitis

1.31

0.37

4.6

4.5

—

Malignant neoplasm of colon, including Hilmo

428

1.14

0.37

3.9

4.2

—

Other and unspecified iridocyclitis

1.39

0.37

2.5

4.7

—

Polycystic ovarian syndrome, broad definition

1.39

0.36

4.5

3.4

—

Benign neoplasm: Skin of ear and external auricular canal

1.36

0.36

3.9

3.7

—

Other diseases of arteries and capillaries

189

1.22

0.36

3.0

4.2

—

Inflammatory disease of cervix uteri

1.33

0.35

3.1

5.1

—

Other disorders of pigmentation

0.66

0.35

7.6

3.6

—

Fall on and from ladder

171

1.23

0.35

3.0

3.8

—

Malignant neoplasm, without specification of site, including Hilmo

1.33

0.35

4.0

—

Delivery, wide proxy

307

0.88

0.35

4.5

3.8

—

Left hemicolectomy

1.43

0.35

10.3

4.3

—

Prurigo nodularis

1.43

0.35

5.2

4.4

—

Pedal cyclist injured in collision with motor vehicle

1.43

0.35

2.2

5.9

—

Viral meningitis

1.43

0.35

3.8

5.1

—

Abnormal blood-pressure reading, without diagnosis

1.43

0.35

4.0

3.5

—

Traumatic subarachnoid haemorrhage

0.63

0.35

4.6

3.9

—

Brain meningioma, including Hilmo

0.63

0.35

4.0

5.3

—

Sub-endpoint used in defining T1D endpoints

583

1.11

0.35

5.2

4.0

—

Otalgia

117

1.28

0.35

2.9

4.4

—

Viral meningitis, including avohilmo

1.40

0.35

3.8

5.0

—

Malignant neoplasm of breast, HER-negative

325

1.15

0.34

6.3

4.2

—

Left ventricular outflow tract obstruction, narrow definition

1.37

0.34

2.7

5.8

—

Benign neoplasm: Descending colon

156

0.77

0.34

4.7

3.7

—

Complications following abortion and ectopic and molar pregnancy

1.37

0.34

4.7

5.5

—

Open wound of hip and thigh

1.37

0.34

2.5

4.7

—

Type1 diabetes, definitions combined, early onset

1.36

0.34

2.3

6.7

—

Other noninflammatory disorders of uterus, except cervix

244

1.15

0.34

4.1

4.3

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.34

0.34

3.1

4.4

—

Carcinoma in situ of skin of lower limb, including hip

1.34

0.34

2.5

4.4

—

Primary angle-closure glaucoma

1.32

0.33

4.5

4.0

—

Anorexia (incl.atypical)

1.33

0.33

4.3

4.6

—

Benign neoplasm: Skin of eyelid, including canthus

349

1.15

0.33

3.4

3.9

—

Nontoxic single thyroid nodule

118

1.27

0.33

4.6

4.7

—

Lichen planus

265

1.17

0.33

4.2

4.0

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.31

0.33

3.2

3.8

—

Amblyopia ex anopsia

1.31

0.33

4.3

6.5

—

Other disorders of prostate

0.67

0.33

4.8

3.2

—

Maternal care for other known or suspected fetal problems

102

1.23

0.32

5.0

3.9

—

Parkinson's disease

413

0.87

0.32

2.8

4.0

—

Contact with nonpowered hand tool

1.35

0.32

3.4

4.5

—

Obesity, other/unspecified

578

1.11

0.32

3.6

4.2

—

Follow-up examination after treatment for malignant neoplasms

229

1.18

0.32

2.8

4.0

—

Other noninflammatory disorders of vagina

1.33

0.32

4.5

4.1

—

Coeliac disease

192

1.20

0.32

4.8

4.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

165

0.79

0.32

3.6

4.0

—

Tonsillectomy and adenotomy

558

0.91

0.32

4.0

4.1

—

Superficial injury of wrist and hand

332

1.15

0.32

4.7

4.1

—

Diabetic maculopathy

258

0.84

0.31

2.9

3.9

—

Stenosis and insufficiency of lacrimal passages

174

1.21

0.31

4.1

4.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

346

1.14

0.31

6.0

4.2

—

Secondary parkinsonism

1.35

0.31

3.1

4.2

—

Aneurysms, operations, SAH

369

0.87

0.31

3.4

4.0

—

Benign neoplasm of major salivary glands

202

1.19

0.31

3.1

4.0

—

Focal epilepsy

453

0.88

0.30

4.9

4.1

—

Embolic stroke with flimmer

1.30

0.30

3.4

3.6

—

Unspecified abortion

1.30

0.30

2.9

5.1

—

Desensitization to allergens

1.30

0.30

4.0

6.1

—

Impacted cerumen

272

0.84

0.30

5.7

4.0

—

Endometriosis ASRM stages 3,4

336

0.86

0.30

3.5

4.1

—

Thyrotoxicosis, other and/or unspecified

362

1.13

0.30

4.0

4.1

—

Parkinson's disease, including avohilmo

431

0.88

0.30

2.7

4.0

—

Pathological resorption of teeth

1.27

0.30

2.7

4.9

—

Hyperkinetic disorders

1.31

0.29

12.7

4.9

—

severe traumatic brain injury, does not include concussion

609

0.90

0.29

3.6

3.8

—

Erosion of teeth , including avohilmo

441

0.88

0.29

4.5

4.0

—

Rheumatic fever incl heart disease

1.25

0.29

3.6

4.3

—

Abrasion of teeth

736

1.09

0.29

4.7

3.9

—

Anomalies of dental arch relationship, including avohilmo

243

1.15

0.29

5.8

4.3

—

Other appendicitis

139

1.22

0.29

2.4

4.5

—

Parkinson's disease, excluding more controls

291

1.14

0.28

2.7

3.9

—

Impingement syndrome of shoulder

488

1.11

0.28

3.9

4.1

—

Cholesteatoma of middle ear

103

1.26

0.28

3.2

3.7

—

Disturbances of smell and taste

1.29

0.28

2.9

4.2

—

Thyroiditis

1.28

0.28

5.4

4.5

—

Neuralgia and neuritis, unspecified

1.30

0.28

4.2

4.5

—

Schizoaffective disorder

1.28

0.28

2.3

4.3

—

Malignant neoplasm, without specification of site

1.27

0.27

4.3

4.0

—

Pterygium

1.25

0.27

4.1

3.9

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

120

0.75

0.27

4.1

4.7

—

Acne, including avohilmo

143

1.19

0.27

3.2

4.3

—

Other degenerative diseases of the nervous system

487

0.91

0.26

3.7

3.8

—

Other other unspecified disorders of the circulatory system

1.21

0.26

6.8

4.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

245

1.15

0.26

2.8

4.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

273

1.14

0.26

2.8

4.4

—

Malignant neoplasm of brain, including Hilmo

0.69

0.26

4.6

5.0

—

Separation of retinal layers (serosa)

0.67

0.26

1.8

4.3

—

Other disorders of male genital organs

1.25

0.25

3.1

4.7

—

Malignant neoplasm of ovary

1.25

0.25

4.1

5.8

—

Sulfonylureas

840

0.94

0.25

3.4

3.8

—

Traumatic amputation of wrist and hand

1.20

0.25

2.6

3.6

—

Malignant neoplasm of pancreas, including Hilmo

179

1.17

0.25

3.5

4.6

—

Pedal cyclist injured in noncollision transport accidents

179

1.17

0.25

3.8

4.6

—

Melanocytic naevi

612

0.91

0.25

5.0

3.9

—

Other local infections of skin and subcutaneous tissue

198

1.16

0.24

5.6

4.0

—

Uterine polyps

259

1.11

0.24

3.9

4.2

—

Pre-eclampsia or poor fetal growth

348

1.12

0.24

3.7

4.4

—

Mental disorders, not otherwise specified

1.27

0.24

2.4

4.6

—

Benign neoplasm of other and ill-defined parts of digestive system

407

1.11

0.24

4.1

3.9

—

Other diseases of gallbladder

1.28

0.24

3.3

4.3

—

Malignant neoplasm of kidney, except renal pelvis

189

1.16

0.24

3.0

4.9

—

Congenital malformations of genital organs

1.16

0.24

4.9

5.8

—

Benign neoplasm: Small intestine

0.71

0.24

3.0

3.7

—

Female infertility, cervical, vaginal, other or unspecified origin

204

0.88

0.24

4.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

114

1.22

0.24

4.2

5.1

—

Abnormalities of forces of labour

0.71

0.24

3.8

4.1

—

Exposure to other and unspecified inanimate mechanical forces

115

1.22

0.23

4.1

4.7

—

Benign neoplasm: Cerebral meninges

190

0.84

0.23

2.9

4.2

—

Background retinopathy and retinal vascular changes

1.32

0.23

4.8

4.1

—

Postpartum haemorrhage

195

1.14

0.23

4.9

4.1

—

Campylobacter enteritis

1.32

0.23

5.8

3.9

—

Other facial nerve disorders

1.32

0.23

7.4

3.5

—

Ganglion

351

1.11

0.23

3.1

4.2

—

False labour

158

1.14

0.23

4.6

4.2

—

Labour and delivery complicated by fetal stress [distress]

110

0.83

0.23

4.0

3.5

—

Embolic stroke

125

0.80

0.23

3.7

—

Problems related to social environment

1.28

0.23

2.6

4.6

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

640

1.08

0.22

3.2

4.1

—

Periodontal disease, other/unspecified

1.25

0.22

4.0

3.8

—

Gonococcal infection

1.25

0.22

2.2

4.4

—

Abnormal findings on antenatal screening of mother

1.25

0.22

3.0

3.9

—

Aortic valve malfunction, age under 60 years

157

0.83

0.22

3.6

4.1

—

LSIL lesion of the cervix uteri, vagina or vulva

153

1.18

0.22

4.1

4.3

—

Struck by thrown, projected or falling objec

1.27

0.22

3.2

4.6

—

Eating disorders

1.25

0.22

3.8

4.2

—

Vascular dementia (undefined)

124

1.20

0.22

2.8

3.6

—

Single delivery by caesarean section

0.82

0.22

6.4

3.7

—

Nontoxic diffuse goitre

1.22

0.22

4.0

4.6

—

Vitamin B12 deficiency anaemia

229

1.14

0.21

5.3

3.5

—

Chronic myringitis

0.00

0.21

0.0

7.7

—

LeFortI or BSSO operation

1.19

0.21

3.8

5.0

—

Drug-induced tremor

0.00

0.21

0.0

7.7

—

Open bite

1.19

0.21

5.6

6.8

—

Migraine, unspecified, drug-induced

0.00

0.21

0.0

7.6

—

Carcinoma in situ of breast, lobular

0.00

0.21

0.0

8.2

—

Dissection of cerebral arteries, nonruptured

0.00

0.21

0.0

6.0

—

Effects of heat and light

0.00

0.21

0.0

7.9

—

Benign neoplasm: Pharynx, unspecified

0.00

0.21

0.0

7.5

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.21

0.0

7.6

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

0.21

0.0

5.3

—

Thyrotoxicosis with toxic single thyroid nodule

0.00

0.21

0.0

7.7

—

Exposure to excessive heat of man-made origin

0.00

0.21

0.0

5.0

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

0.21

0.0

6.2

—

Other injuries of spine and trunk, level unspecified

0.00

0.21

0.0

5.1

—

Malignant neoplasm of parotid gland, including Hilmo

0.00

0.21

0.0

4.9

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.21

0.0

8.3

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.21

0.0

9.8

—

Other disorders of binocular vision

0.00

0.21

0.0

7.6

—

Hydatidiform mole

0.00

0.21

0.0

5.8

—

Gender identity disorders

0.00

0.21

0.0

4.0

—

Disorders in reading

0.00

0.21

0.0

13.7

—

Complications associated with artificial fertilization

0.00

0.21

0.0

3.0

—

Habitual aborter

0.00

0.21

0.0

3.0

—

Tetraplegia

0.00

0.21

0.0

7.1

—

Ductal carcinoma of pancreas

0.00

0.21

0.0

5.3

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.21

0.0

4.0

—

Leukaemia of unspecified cell type

0.00

0.21

0.0

7.4

—

Migraine with aura, drug-induced

0.00

0.21

0.0

7.3

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

0.21

0.0

14.8

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.21

0.0

6.8

—

Ovarian hyperstimulation (induction)

0.00

0.21

0.0

3.4

—

Follicular cysts of skin and subcutaneous tissue

367

0.90

0.21

3.5

4.0

—

Procreative management

425

1.08

0.21

5.5

4.3

—

Congenital malformations of great arteries

0.00

0.21

0.0

14.7

—

Injury of muscle and tendon at lower leg level

296

1.12

0.21

4.2

3.9

—

Endovascular or surgical operations to intracerebral aneurysms

103

0.78

0.21

2.9

4.6

—

Other and unspecified mononeuropathies of upper limb

1.16

0.21

2.4

4.2

—

Hypogonadotropic hypogonadism

1.16

0.21

3.8

4.7

—

Purulent endophthalmitis

0.00

0.21

0.0

7.5

—

Sequelae of poliomyelitis

0.00

0.21

0.0

6.7

—

Contact with venomous snakes and lizards

0.00

0.21

0.0

6.6

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.21

0.0

7.1

—

Endometriosis of intestine

0.00

0.21

0.0

3.0

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

5.2

—

Other and unspecified mental retardation

0.00

0.20

0.0

13.6

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.20

0.0

6.8

—

Single spontaneous delivery

364

0.93

0.20

4.4

3.9

—

Pigmented purpuric dermatosis

0.00

0.20

0.0

3.1

—

Pedestrian injured in other and unspecified transport accidents

0.00

0.20

0.0

6.3

—

Use of glatiramer acetate

0.00

0.20

0.0

5.2

—

Parkinson's disease, strict definition, excluding more controls

277

1.11

0.20

2.8

3.9

—

Otosclerosis

136

1.18

0.20

2.6

4.3

—

Hyperaldosteronism

1.23

0.20

2.3

4.5

—

Car occupant injured in noncollision transport accident

1.23

0.20

2.8

4.5

—

Chondrocostal junction syndrome [Tietze]

1.23

0.20

2.8

4.7

—

Male infertility

1.23

0.20

9.7

3.2

—

Medical treatment for female infertility

164

0.85

0.20

5.7

4.2

—

Conjunctivitis (acute, non atopic), including avohilmo

254

1481

1.03

0.20

3.7

4.0

—

Benign neoplasm: Colon, unspecified

674

1.07

0.20

4.1

3.8

—

Other/unspecified reactive arthropathies

1.21

0.19

6.2

4.2

—

Malignant neoplasm of urinary organs

212

1.13

0.19

3.0

4.8

—

Medial epicondylitis

1.18

0.19

5.7

5.4

—

Lesion of lateral popliteal nerve

1.22

0.19

4.6

3.9

—

Dislocation, sprain and strain of joints and ligaments of knee

124

1068

1.05

0.19

3.9

4.2

—

Use of levodopa decarboxylase inhibitor

385

0.91

0.19

2.7

3.9

—

Volvulus

1.15

0.19

4.0

4.4

—

Cystic kidney disease, including avohilmo

1.15

0.19

2.0

4.2

—

Other and unspecified injuries of shoulder and upper arm

1.15

0.19

2.7

5.2

—

Gingival hyperplasia

1.15

0.19

3.2

4.4

—

Contusion of ankle

1.15

0.19

3.5

5.9

—

Appendectomy

139

1265

1.05

0.19

3.6

4.1

—

Tooth eruption problems

105

1.20

0.19

4.8

4.7

—

Other specified disorders of external ear

1.24

0.18

2.9

3.7

—

Vascular dementia

279

1.11

0.18

3.0

3.7

—

Unspecified urinary incontinence

175

1.14

0.18

3.0

4.7

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

477

0.92

0.18

4.0

3.9

—

Osteomyelitis

128

1.17

0.18

2.8

4.1

—

Foreign body entering into or through eye or natural orifice

128

1.17

0.18

3.5

4.5

—

Divergent concomitant strabismus

100

1.20

0.18

2.6

4.1

—

Impacted teeth

134

1.15

0.18

4.6

4.3

—

Other noninflammatory disorders of cervix uteri

1.19

0.18

2.9

4.6

—

Malignant neoplasm of pancreas

153

0.85

0.18

3.2

4.4

—

Melanocytic naevi of lower limb, including hip

1.17

0.17

4.9

4.0

—

Other disorders of breast

195

0.87

0.17

4.2

—

Burns and corrosions of external body surface, specified by site

176

1.14

0.17

6.4

4.4

—

Benign neoplasm: Transverse colon

262

1.11

0.17

5.1

3.9

—

Acute alcohol intoxication ICD-9

1.13

0.17

2.6

4.0

—

Mandibular retrognathia

1.13

0.17

9.9

6.1

—

Ectopic pregnancy

243

1.11

0.17

2.8

4.8

—

Other symptoms and signs involving cognitive functions and awareness

133

1130

1.04

0.17

3.8

—

Other obstructive and reflux uropathy

0.75

0.17

5.4

4.1

—

Pre-eclampsia

253

1.11

0.16

3.7

4.3

—

Foreign body in respiratory tract

0.71

0.16

2.6

4.2

—

Examination and encounter for administrative purposes

173

0.87

0.16

3.7

3.6

—

Other congenital malformations of skin, including avohilmo

101

1.19

0.16

3.8

5.9

—

Congenital malformations of heart and great arteries

190

1.12

0.16

3.2

4.5

—

Injuries to unspecified part of trunk, limb or body region

196

1.12

0.16

3.4

4.7

—

Visual impairment including blindness (binocular or monocular)

139

1.15

0.16

3.8

4.1

—

Epilepsy

581

1.06

0.16

4.3

3.9

—

Myopia

162

0.86

0.16

6.1

4.8

—

Event of undetermined intent

1.20

0.16

3.8

5.3

—

Organic, including symptomatic, mental disorders

167

1133

1.04

0.16

3.4

3.9

—

Lesion of plantar nerve

111

1.17

0.15

2.7

4.5

—

Congenital malformations of the urinary system

0.76

0.15

2.2

5.5

—

Hordeolum and other deep inflammation of eyelid

1.21

0.15

3.0

3.7

—

Autoimmune hyperthyroidism

1.15

0.15

4.1

3.8

—

Benign neoplasm of meninges

203

0.89

0.15

3.9

4.2

—

Malignant melanoma of skin, including Hilmo

303

1.09

0.15

3.3

4.4

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

121

1.16

0.15

4.1

3.8

—

Other maternal disorders predominantly related to pregnancy

512

1.05

0.14

3.8

4.2

—

Female infertility

209

0.92

0.14

4.1

4.2

—

Colon adenocarcinoma

265

1.09

0.14

3.8

4.5

—

Other otitis externa (chronic)

112

1.16

0.14

2.9

4.4

—

Allergic contact dermatitis

198

1.11

0.14

7.1

4.1

—

Oral lichen planus, including avohilmo , including avohilmo

118

0.85

0.14

2.3

4.7

—

Other and unspecified vascular occlusions

227

1.10

0.14

4.4

3.8

—

Type 1 diabetes, definitions combined

1.18

0.14

3.5

3.6

—

Benign neoplasm: Rectum

460

1.07

0.14

3.6

4.0

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

0.83

0.13

4.6

4.1

—

Use of selegiline

0.82

0.13

2.6

3.8

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.83

0.13

3.8

4.8

—

Pedal cyclist injured in transport accident

402

1.07

0.13

3.9

4.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

586

1.05

0.13

5.1

3.7

—

Benign neoplasm: Colon

153

1481

0.97

0.13

4.2

3.8

—

Alcoholic liver disease

228

1.10

0.13

2.4

3.8

—

All dysplastic lesions of the cervix uteri

253

1.09

0.13

4.1

4.4

—

Malignant neoplasm of rectum

211

0.90

0.13

2.8

4.8

—

Complications predominantly related to the puerperium

335

0.93

0.13

4.9

4.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

333

1.06

0.12

4.2

4.5

—

Deep bite

121

0.87

0.12

2.8

5.0

—

Malignant neoplasm of colon

345

1.07

0.12

3.9

4.3

—

Type 1 diabetes, strict (exclude DM2)

1.17

0.12

3.5

4.8

—

Melanocytic naevi, other sites/unspecified

123

1.14

0.12

4.6

4.4

—

Migraine without aura and triptan purchases

171

1.11

0.12

6.4

4.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

104

1.15

0.12

4.3

4.0

—

Hydrocele

307

1.08

0.12

3.2

3.7

—

Sequelae of injuries of upper limb

162

1.11

0.11

4.2

—

Diabetic maculopathy, excluding more controls

220

1.09

0.11

7.3

3.8

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium tuberculosis genotype [Identifier] in Isolate

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS